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1. INTRODUCTION 
1.1. Definition: 
Pseudotumor cerebri is a clinical syndrome characterised by the 
presence of raised intracranial pressure in an otherwise alert 
patient.It occurs in the absence of localizing neurologic 
abnormalities.False localizing signs such as VI nerve paresis are 
seen in some patients.CSF is normal except for increased pressure 
and there is no radiological evidence of an expanding mass or 
ventricular obstruction(l). 
The terms Pseudotumor Cerebri CPTC) and Benign Intracranial 
Hypertension are used interchangeably in the literature.Since it 
was first described,there has been much argument as to the most 
suitable name for the disorder.For this reason a brief history of 
the syndrome is outlined,highlighting some of the interesting and 
controversial aspects of the syndrome as well as its 
nomenclature. 
1.2. History: 
This condition was probably first described by Quincke (2) in 
1893.He wrote about a group of chiefly young women who had 
developed "cerebral symptoms such as headache,vomiting and optic 
neuritis".A number of these patients recovered completely and no 
cause could be found for their symptoms.He attributed this 
phenomenon to the development of a cerebral effusion of serous 
fluid resulting from altered "vasomotor changes" in the brain 
which he called angioneurotic in origin.Although some patients 
probably did have what is today recognised as PTC,Quincke also 
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suggested that many nervous and so called neurasthenic headaches 
were due to this cause. 
Later in 1913,Warrington (3) described a group of patients who 
had the clinical manifestations of either acute or chronic raised 
intracranial pressure.In these patients,the course of the disease 
(or on occasion the post-mortem evidence) showed the cause not to 
be due to a cerebral tumour or the "commoner form of 
meningitis".He attributed this to the occurrence of a serous 
effusion in the skull which he believed to be inflammatory in 
origin and a manifestation of some other primary pathologic 
process.He felt that in many cases a near or distant focus of 
infection produced toxins which stimulated the vessels of the 
meninges,brain and ependyma to form a serous effusion.He 
suggested that the raised intracranial pressure was the cause of 
the symptoms and required relief independent of its 
origin.Although Warringtons patients had signs of raised 
intracranial pressure simulating "the gravest cerebral disease", 
many subsequently recovered by natural processes or by the aid of 
procedures such as decompression.Present day scrutiny shows that 
his patients were largely a heterogenous group which included for 
example patients with probable tuberculous and other infective 
meningitides and post traumatic obstructive hydrocephalus. 
At almost the same time,Passot had published his thesis in the 
French literature,the main points of which are discussed in full 
in the English literature by Sir Charles Symonds (4) (5).He stated 
that it was important to distinguish those patients in whom the 
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CSF was abnormal from those in whom the chemical and microscopic 
examination of the CSF was entirely normal.He believed that any 
excess of cells or protein in the CSF constituted the preliminary 
stages of purulent meningitis.He felt that those patients in whom 
the CSF was normal constituted a distinct clinical group as they 
presented with neither clinical nor serological evidence of 
meningeal inflammation.He observed that this condition could be 
relieved by LP which showed the spinal fluid to be under 
increased pressure but to be normal on microscopic and chemical 
examination.He believed that this was due to excess fluid in the 
subarachnoid space rather than in the ventricles and recognised 
that secondary optic atrophy and blindness may develop if the 
condition of increased intracranial pressure was unrelieved. 
In 1931,Symonds (5) noted that a not uncommon complication of 
either acute or chronic otitis media with or without mastoiditis 
or lateral sinus thrombosis,was a state of raised intracranial 
pressure which he attributed to an excess amount of CSF which was 
otherwise normal.He suggested the term "Otitic Hydrocephalus" 
which implied no active process of inflammation.This 
term,deprived of the qualification of either "internal" or 
"external",would,he argued, therefore be inclusive of both fluid 
in the ventricles and the subarachnoid space.Symonds used the 
term hydrocephalus in a strict sense to mean an abnormal 
accumulation of fluid in the head and this was not necessarily 
accompanied by enlarged ventricles.Although the pathology was 
obscure,he felt that this was either due to increased secretion 
from the choroid plexus or a defective absorption through the 
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arachnoid villi.He recognised that headache and papilloedema were 
the most consistent findings and also noted the not infrequent 
occurrence of VI nerve palsies in a number of cases.The 
temperature and the pulse were normal in this condition and he 
observed that "mental state may be remarkably clear considering 
the degree of papilloedema".Earlier papers give much attention to 
the differential diagnosis (based on clinical parameters and the 
CSF findings) between this syndrome and other diseases such as 
obstructive internal hydrocephalus and cerebral abscess (5). 
It was not until a report by Davidoff and Dyke (6) in 1936 that 
PTC was shown to occur in the presence of a normal ventricular 
system.Case reports in the literature prior to 1936 are open to 
some doubt as mass lesions had not been excluded on all by air 
encephalography or carotid angiography. 
As different parameters were being defined,by successive 
authors,so too were different names suggested for the syndrome.As 
can be seen from the literature many authors have had great 
difficulty in finding an appropriate name for the syndrome.It has 
in the past been called Serous Meningitis,Otitic Hydrocephalus, 
Hypertensive Meningeal Hydrops and Brain Swelling of Unknown 
Cause.Serous meningitis was refuted as clearly this was not an 
inflammatory disease.Symonds's suggestion of "otitic 
hydrocephalus" was also felt to be inappropriate as many patients 
were shown not to have evidence of middle ear disease and 
subsequently air studies showed no evidence of hydrocephalus. 
The term" Benign intracranial Hypertension"(?) dates back to 
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1955 and is still in use today.The syndrome is considered to be 
both benign and self-limiting but it may be associated with 
severe visual loss thereby becoming an extremely urgent condition 
requiring intervention.The term "benign" refers to the fact that 
no tumour is found and that the condition does not threaten the 
patient's life,but it is open to misinterpretation in that it may 
lead some to believe that the disorder has no serious 
sequelae.The term "benign" is certainly inappropiate when applied 
to visual status.For this reason the name "Pseudotumor Cerebri" 
for the syndrome,is preferred by this author.This study directs 
particular attention to the visual status in patients with this 
syndrome. 
~ Aetiology: 
The precise aetiology of this condition remains uncertain and 
controversy exists regarding the contribution of various 
factors. 
This syndrome has been frequently reported as a result of 
cerebral venous sinus thrombosis ( often following middle ear 
infection (1) (8) particularly in the earlier reports in the 
pre-antibiotic era).The literature cites a number of likely 
mechanisms for the development of PTC complicating a dural sinus 
thrombosis.The venous sinus thrombosis may increase the 
intracranial pressure by increasing intracranial CSF outflow 
resistance and or by direct transmission of elevated intracranial 
venous pressure to the CSF pathways.In addition,the cerebral 
swelling associated with the venous occlusion and congestion is 
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another factor liable to contribute to the development of the 
syndrome. 
With the exception of those patients with venous occlusion,the 
pathophysiology of intracranial hypertension in the various forms 
of the disorder is poorly understood. A variety of factors have 
been implicated in causing this syndrome but the mechanisms are 
unknown or obscure. 
PTC has been noted to be associated with drug ingestion notably 
tetracycline,naladixic acid,corticosteroid therapy and 
withdrawal, oral progestational contraceptive agents,and vitamin 
· A.However the use of medications such as tetracyclines or 
steroids are associated with a very small percentage of the 
number of cases with PTC in any series.The likelihood of PTC 
developing during tetracycline or steroid withdrawal is 
undoubtedly small when the frequent use of these agents is 
considered. 
Obesity as a contributing factor has been noted in as many as 90/o 
of cases in some studies but weight gain Just prior to the onset 
of the disorder is seldom noted. Menstrual irregularities have 
also been documented in some patients and the syndrome has been 
observed to occur in pregnancy (9) (10) and in some patients with 
galactorrhoea.Although the association of PTC with menstrual 
irregularities,pregnancy and oral contraceptives has been 
stressed by many authors,these associations occur only in a few 
patients.Furthermore the incidence of these findings has not been 
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adjusted for the expected incidence in normal female subjects or 
otherwise normal,obese female subjects (11). 
The syndrome has been recorded in diverse systemic conditions 
such as iron deficiency anaemia,sarcoidosis,systemic lupus 
erythematosis,Behcets disease,hypoparathyroidism and Addison's 
Disease (12) (13) (14) (15) (16) (17) .PTC has also been described 
following various infections such as poliomyelitis,infectious 
mononucleosis and upper respiratory and urinary tract 
infections.It is not known whether these illnesses were simply 
chance associations. Pseudotumor Cerebri has been reported in 
association with the Guillain Barre syndrome (9) (18). 
A small percentage of patients in some series (19) (20) described 
mild head injury just before the onset of symptoms.These episodes 
were not severe enough to necessitate hospitalization and were 
generally reported as mild concussion or even less severe head 
injuries.Once again it is unclear whether these episodes simply 
represent chance associations but it is conceivable that some of 
these patients had traumatic cerebral sinus thrombosis. 
In many cases no aetiological agent or disease is identified. 
Some authors (11) tend to distinguish between the condition when 
it occurs as a result of proven dural venous sinus thrombosis and 
when it occurs without any definite or probable cause. It is 
likely that the syndrome encompasses a number of different 
conditions with possible different pathogenic mechanisms.This has 
lead some workers (21) to reserve the term PTC for the group of 
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young obese women with the syndrome and no obvious underlying 
cause. However it is not known whether the pathogenic mechanisms 
are different in the two groups,nor whether they differ in any 
way in their presentation or response to treatment.As the term 
PTC refers to a clinical syndrome and not necessarily a single 
disease process,it seems pointless to restrict its use to the 
idiopathic group only. 
2. AIMS OF STUDY: 
1.To analyse the patients . who have been treated at Groote Schuur 
Hospital over the last seven years for Pseudotumor Cerebri. 
2.To document the clinical features of this group of patients. 
3.To determine the visual prognosis of this group. 
4.To assess the forms of treatment that have been used in this 
group. 
5.To review the literature with regard to: 
a)a comparison of the results of other studies with the 
present one. 
b)the pathophysiology of the condition. 
c)treatment of the syndrome. 
d)the visual prognosis of the syndrome. 
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3. DIAGNOSTIC CRITERIA: 
There is consensus in the literature concerning the diagnostic 
criteria for the syndrome.It is largely accepted that criteria 
for the diagnosis (6) (9) (11) (20) (22) (23) should include the 
following: 
1.The symptoms and clinical signs are due to the presence of 
raised intracranial pressure alone. 
2.Lumbar CSF pressures are elevated above 200mm water. 
3.CSF composition is normal in terms of protein,sugar and cell 
count. 
4.Neuroradiological investigations show no evidence of an 
intracranial mass or ventricular obstruction. 
4. METHODS: 
1.Retrospective analysis utilizing computer retrieval of all 
patients admitted to GSH during the last seven years with the 
disorder. 
2.Analysis of Department of Neurology records as well as the 
entire medical folders of each patient known to have the 
syndrome. 
3.Selection of patients to be included in the study to meet with 
recognised diagnostic criteria as stated above. 
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4.1. Parameters: 
Analysis of records with regard to: 
!.Predisposing or precipitating factors. 
2.Clinical parameters including onset,symptoms and neurological 
signs,including visual deficit at time of diagnosis. 
3.Special investigations. 
4.Follow-up period and duration. 
5.Ultimate visual deficit. 
4.2. Patients: 
The Groote Schuur Hospital computerised record system was used to 
identify all patients with Pseudotumor Cerebri admitted between 
January 1981 and December 1987. 
During this seven year period 52 patients were admitted to the 
hospital where a diagnosis of PTC was made. 
Scrutiny of the medical notes showed that in 15 of these patients 
the diagnosis of PTC was incorrect as the clinical findings and 
investigations strongly favoured an alternate diagnosis (such as 
cysticercosis,intracerebral haemorrhage,inflammatory 
disease,traumatic skull fractures,and cases where the data was 
inadequate to make a firm diagnosis). 
In a further 7 patients the diagnosis was thought to be 
compatible with PTC but these were excluded from this study 
because all the diagnostic criteria as outlined above were not 
fulfilled.These inluded patients in whom the CSF cell count or 
chemistry are not recorded and those in whom the CSF pressure 
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readings were inaccurately measured (eg. measured after the CSF 
was drained or soon after an osmotic diuretic had been given). 
A total of 30 patients fulfilled all the diagnostic criteria and 
were included in this study. 
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5. RESULTS: 
5.1. Sex and Race Distribution: 
Total no of male patients: 6 
Total no of female patients: 24 
Male to female ratio: 1: 4 
Total no of White patients: 5 
Total no of Coloured patients: 22 




5.2. Hospital Department in which patients were treated: 
Patients with PTC were often admitted and treated by different 
clinical services at Groote Schuur Hospital.The breakdown of 
where patients in this study were treated is listed below. 
GSH Dept: 
Neurology Service: 18 patients 
Ophthalmology Service: 2 patients 
Neurosurgery Service: 2 patients 
Paediatric Service: 4 patients 
Medical Wards: 4 patients 
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5.3. Age of onset: 
Mean age of onset for PTC: 29 years range: 4 to 51 years 
Approximately half the patients (14/30patients) developed PTC 
between the ages of 20 to 40 years.The distribution for age of 
onset is illustrated graphically below: 
Figure no.1 
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5.4. Associated conditions: 
A possible predisposing factor at the time of presentation was 
noted in 50Y. (15/30) of the patients in this study. 
4 patients had two predisposing factors for the syndrome. 
These factors are listed below: 
Infections: 
4 patients had a history of a febrile "flu-like" illness within 
two weeks prior to the onset symptoms. 
1 patient had an acute left otitis media at the time of 
presentation. 
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Minor head trauma: 
1 patient gave a history of minor head trauma prior to onset of 
symptoms. 
Drugs: 
11 patients were taking one or more drugs known to be associated 







intramuscular contraceptive: 1 patient 
(3 patients were taking 2 drugs associated with PTC) 
Menstrual irregularities: 
2 patients gave histories of menstrual irregularities. 
5.5. CLINICAL PRESENTATION: 
5.5.1. Symptoms: 
Table no.1 
A table of presenting symptoms of the 30 patients with PTC is 
illustrated below: 
symptom number percent 
headache 28 93Y. 
visual obscurations and blurring 18 60Y. 
diplopia 10 33Y. 
vomiting 10 33Y. 
dizziness 3 lOY. 
pain left mastoid area 1 3Y. 
5kg weight gain in 1 month 1 3Y. 
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The duration of the headache prior to the diagnosis being made 
varied from 5 days to 1 year in this group.In 67X of these 
patients (20/30) the duration of the headache was a month or 
less.In those patients who complained of headache for a period of 
6 months or more (4 patients) it was not possible on 
retrospective analysis to determine whether this was due to 
failure of these patients to seek medical attention or whether 
incorrect medical assessments had previously been made. 
The duration of the visual disturbances (which included transient 
obscurations in one or both eyes or persistant blurring) was less 
accurately documented in the records but patients with this 
symptom tended to seek advice within 1 month of onset of this 
symptom.One patient complained of transient visual obscurations 
("black patches before the eyes") for a whole year before coming 
to hospital. 
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16 patients (53Y.) were recorded as 
obese 
27 patients were normotensive and 3 patients 
had mild hypertension (150/100;160/95;and 
140/100) on presentation. 
papilloedema: lOOY. of patients had papilloedema 
Sixth nerve palsies:9 patients (30Y.) had 6th nerve palsies.This 
other: 
was bilateral in 6 patients and 
unilateral(all on the left) in 3 patients. 
1 patient had acute otitis media on 
admission; 
2 patients had mild unilateral lower motor 
neurone facial weakness which resolved 
completely on treatment; 
1 patient already had optic atrophy at time 
of first assessment; 
1 patient had a cataract; 
1 patient had an ejection systolic murmur; 
and 1 patient developed painful ulcers on 
lateral border of her tongue and at 
venipuncture sites. 
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5.6. VISUAL FUNCTION (at diagnosis): 
Visual function was assessed by testing visual acuity as well as 
visual fields,with formal perimetry being done in the 
ophthalmology department. 
5.6.1. Visual Acuity: 
Best corrected visual acuity was done with the standard Snellen 
chart. 
Normal visual acuity was recorded on 14 patients (47%) at the 
time of diagnosis (all had acuities of 6/6 bilaterally except for 
2 with acuities of 6/7.5). 
Visual acuity was not tested at time of diagnosis in 2 patients. 
Visual acuity was found to be abnormal in 14 patients (47%) at 
first assessment.This includes all patients who had visual 
acuities of 6/9 or worse in one or both eyes. 
Visual acuity was impaired in both eyes in 10 patients. 
Visual acuity was impaired in one eye only in 4 
patients 
Visual acuity was found to be 6/18 or worse in either eye in 6 
patients (20X).One patient whose vision was reduced by a cataract 
to counting fingers was not included in this figure. 
5.6.2. Visual Fields: 
Formal perimetry was done on the Goldmann perimeter,or the 
Friedmann Field Analyser,or more recently on the automated 
computerized perimeter.The Friedmann Analyser utilizes a series 
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of filters which reduce the intensity of the light source thereby 
increasing the sensitivity of the test. 
13 patients (43Y.) had full visual fields on formal testing at the 
time of diagnosis of PTC. 
5 patients (17Y.) did not have their visual fields formally tested 
at time of diagnosis. 
12 patients (40Y.) had impaired visual fields at first assessment 
(excluding enlarged blind spots). 
5 patients had peripheral field constriction (bilateral in 
3) 
3 patients had impaired visual fields with reduced 
sensitivity to the 
filters on the 
Friedmann Analyser. 
2 patients had inferior visual field defects 
1 patient had a temporal field defect. 
1 patient had bilateral patchy loss of visual fields 
Of these 12 patients with impaired fields at first assessment,4 
were found to have normal acuities 
5.7. VISUAL FUNCTION AT LAST ASSESSMENT: 
The visual acuities and fields were analysed at the time of the 
last clinical assessment in this group of patients to determine 
the visual outcome. 
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5.7.1. Final visual acuity: 
13 patients (43/.) had normal visual acuity at the time of the 
last assessment. 
6 patients (20/.) did not have their acuity tested at final 
assessment. 
11 patients (37/.) had impaired visual acuity at last follow-up. 
Of these 11 patients: 
4 patients had final visual acuities in one or both eyes 
which were worse than their acuities at 
presentation. 
3 patients had improved final acuities compared to 
presentation.However,1 of these patients 
developed a rapid bilateral profound 
deterioration of vision while in the ward,and 
although final acuity more than a year later was 
better than at time of diagnosis,the visual 
fields were still profoundly impaired in this 
patient. 
4 patients had visual acuities which were unchanged at 
final assessment compared to the initial 
assessment. 
All 11 patients who had impaired visual acuities at last 
follow-up had impaired acuities at the time of the first 
assessment. 
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5.7.2. Final visual fields: 
9 patients (30Y.} had normal visual fields at the time of the last 
assessment. 
10 patients (33Y.) did not have a final visual field assessment 
done. 
11 patients (37Y.} had impaired visual fields at the time of last 
assessment. Compaired to the initial assessment,final visual 
fields were worse in 4 patients,improved in 1 patient,and 
unchanged in 4 patients.! patient developed a new inferonasal 
defect on the left but had improvement of the previously 
recorded constricted field on the right.The last patient had 
reduced sensitivity to the filters on the Friedmann chart at 
final assessment but as the first chart has been lost,no 
comparison can be made. 
The table on the following page lists the 11 patients with 
impaired visual fields at last assessment noting the final field 
defects,duration of follow-up and outcome: 
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Table no.2: Final Visual Fields 
P.no. Final VF 
4. profound bilat constriction 
with central depression 
6. bilat field constriction 
8. patchy field loss on right 
14. mild field impairment on the R 
15. constricted field on the right 
16. profound field loss on R 
18. full fields but reduced 
sensitivity to filters 
25. bilat field constriction 
27. inferonasal field defect on L 
29. mild bilat arcuate constriction 
30. bilat patchy field loss 
follow-up outcome 
15 mths much worse 
24 mths unchanged 
2 mths worse on R. 
8 mths worse 
2 mths unchanged 
4 mths unchanged 
9 mths not known 
10 mths much worse 
12 mths new defect 
1 week improved 
2 mths unchanged 
Of the 11 patients with impaired final visual fields,9 also had 
impaired visual acuity,1 patient (no.27) had normal acuity and 1 
patient's final acuity is unknown because her eye clinic record 
has been lost. 
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5.7.3. Visual outcome taking both acuity and fields into 
account: 
As visual function was assessed by both visual acuity and visual 
field testing,it is necessary to look at the combined statistics 
for both parameters to determine visual outcome.The combined 
figures are particularly relevant as not all patients had both 
acuity and fields tested ab initio,and at last follow-up. 
A total of 13 patients (43Y.) had impaired visual function (as 
determined by reduced visual acuity or reduced visual fields or 
both) at the time of last assessment. 
12 of the 13 patients had reduced visual function Cby the same 
criteria as above) at time of first assessment. 
18 patients C60Y.) had impaired visual function at time of first 
assessment for PTC. 
Of these: 
3 patients had normal visual function at final 
assessment as determined by BOTH visual acuity and 
fields. 
3 patients probably had normal visual function at final 
assessment but one of the perameters (either acuity 
or fields) were not assessed at the time. 
12 patients were left with a residual visual deficit at 
last assessment.In 6 of these patients visual 
function {viz. either fields or acuity or both) was 
worse at last assessment compared to presentation. 
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The following three tables reflect the parameters of visual 
function at diagnosis and at last assessment: 
Table no.3: 






no of patients Y. 
14 (47Y.) 
2 (6Y. > 
14 (47Y.) 
last assess: 



















VISUAL FUNCTION <VFN> AT DIAGNOSIS AND LAST ASSESSMENT 
(ie. as determined by visual fields and/or visual acuity) 
Normal VFN 
Impaired VFN 
no information of VFN 
available 
initial assess: 












Therefore 13/25 patients (52Y.) [in whom objective measurements 
of VFN are available] were left with a residual deficit at last 
assessment 
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5.7.4. Fundi at last assessment: 
The funduscopic findings were not recorded in 6 patients at the 
last clinical assessment. 
10 patients (33Y.) had normal fundi at last assessment (with the 
duration of follow-up ranging from 2 weeks to 4 years 
with a mean of 15 months). 
6 patients (20Y.) were thought to have improved but still swollen 
discs (with a follow-up period ranging from 1 week to 
18 months with a mean of 6 months). 
4 patients still had swollen discs at follow-up (duration ranging 
from 2 to 33 months). 
3 patients had optic atrophy at follow-up (duration ranging from 
10 to 24 months>. 
2 patients had glial tissue around the disc (1 of whom still had 
swollen discs) at follow-ups of 1 and 3 years 
respectively. 
Of the 15 patients (SOY.) who had abnormal discs at last 
assessment,9 had a residual visual deficit (impaired acuity or 
fields or both). 
[Discussion of visual loss and prognosis on page 37] 
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5.8. CSF Pressure: 
Initial pressures were greater than 400 mm of water in 19 of the 
30 patients (63Y.).In the remaining 11 patients the initial 
pressures were between 200 and 400mm water. 
Only a single lumbar puncture was done in 10 of the 30 patients 
(2 subsequently had LP-shunts inserted).Of note was that 
5 of the 10 patients had a residual visual deficit at 
final assessment. 
In the 20 patients who had more than 1 LP,the last recorded LP 
pressures (which was the second LP reading in 5 of these 
patients) were: 
Normal in 5 patients. 
Increased in 15 patients (with pressures of 
greater than 400 in 8 of the 15) 
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The following table compares the frequency of various presenting 
features with visual deficit at diagnosis and at last 
assessment. 
Table no.6: 
PRESENTING FEATURES AND VISUAL DEFICITS 
PST DX LST NI 
symptoms: 
visual obscurations ....... 18 13 1 1 1 
no obscurations ........... 12 5 2 4 
headache < 1 /12 .....•..... 18 10 8 3 
1/12 to 1 yr . ...... 10 6 3 2 
no headache ....... 2 2 2 0 
age: 
< 20 yrs . ................. 8 4 1 3 
20 to 40 yrs . ............. 14 9 6 1 
> 40 yrs . ................. 8 5 6 1 
sex: 
ma 1 e . .................•... 6 2 1 3 
female .................•.. 24 16 12 2 
weight: 
overweight ................ 16 7 6 4 
normal weight ............. 14 1 1 7 1 
predisposing factors: 
precedant illness ......... 5 1 1 2 
no precedant illness ...... 25 17 12 3 
drug history ...........•.. 11 7 4 3 
no drugs . ................. 19 11 9 2 
Initial CSF pressure: 
pressure < 400 . ........... 1 1 6 5 2 
pressure > 400 . ........... 19 12 8 3 
PTS = number of patients 
DX = number of patients with impaired visual function at time 
of diagnosis. 
LST = number of patients with impaired visual function at time 
last assessment. 
NI = number of patients in which no objective information of 
visual function is available at last assessment. 
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5.9. Radiological Investigations: 
5.9.1. Skull X-Ray (SXR>: 
5 patients did not have a SXR taken. 
17 patients had normal SXR's. 
4 patients had erosion of the dorsum sella on SXR. 
1 patient was thought to have an empty sella syndrome on SXR. 
2 patients had enlarged pituitary fossae on SXR. 
1 patients was noted to have a giant cisterna magna on SXR. 
5.9.2. CT Scan: all 30 patients had CT scans. 
22 patients had a normal scan. 
5 patients were shown to have small ventricles on the scan. 
3 patients had an empty sella on the scan. · 
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5.10. Follow-up Duration of patients with PTC: 
The mean follow-up duration of patients in this study was 296 
days(ie. approx. 10 months) with a range of 7 days to 4 years. 
5 patients had no follow-up at Groote Schuur Hospital (1 patient 
had recovered completely at time of discharge;3 patients were 
discharged to hospitals in other centres;and 1 patient was lost 
to follow-up). 
Of the remaining patients: 
7 patients were followed-up for a period of between 1 week 
and 2 months. 
6 patients for a period of between 2 and 5 months 
2 patients for a period of between 5 and 10 months 
4 patients for a period of between 10 and 15 months 
2 patients for a period of between 15 months and 2 years. 
4 patients for a period of more than 2 years. 
these figures are illustrated graphically below: 
Figure no.2 
II duration of follow-up 
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" o.116 / 
p ,f..fl/ 
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.i .L.fll 
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5.11. Relapse of PTC: 
4 patients had relapses of symptoms with raised pressure after an 
initial improvement.This occurred within 6 months of the first 
episode in all of thse patients. 
5.12. TREATMENT: 
5.12.1. Repeated Lumbar Puncture: 
20 patients had more than one LP: 
5 patients had 2 LP's each. 
8 patients had 3 LP's each. 
6 patients had 4 or more LP's each. 
In 1 patient the exact number of LP's is uncertain 
5.12.2. Drug therapy: 
6 patients did not receive any drug therapy. 
11 patients were treated with one drug only (steroids in 3; 
diuretics in 7;and acetazolamide in 1) 
7 patients were treated with 2 drugs. 
6 patients received 3 drugs. 
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5.12.3. Steroids: 
A total of 16 patients were treated with steroid drugs. 
7 patients were given Dexamethasone (used for 1 month or less in 
most patients but 1 patient was treated with 
Dexamethasone for a year) 
7 patients were given Prednisone (treated for periods ranging 
from 5 days to 5 months) 
2 patients were given Dexamethasone for a short period and then 
followed by Prednisone for 2 months. 
5.12.4. Carbonic Anhydrase Inhibitors (Acetazolamide): 
8 patients were treated with Acetazolamide. 
Duration of treatment ranged from 5 days to 5 months. 
5.12.5. Other Diuretics: 
10 patients received thiazide diuretics,5 patients received 
furosemide,and 2 patients received chlorthalidone. 
Duration of treatment ranged from 1 week to 5 months. 
5.12.6. Surgical treatment: 
5.12.7. Lumba-Peritoneal shunt: 
These shunts were inserted in 4 patients within 6 months after 
presenting with PTC.Indications for the procedure were 
deteriorating visual function and failed medical therapy. 
In 3 patients there was no further visual detioration after the 
shunt was inserted (1 was even shown to have improved 
thereafter).The fourth patient's shunt had to be removed after 9 
months because it had blocked.Visual fields have not been 
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retested after the removal of the shunt. 
5.12.8. Optic Nerve Decompression: 
2 patients had had this procedure done for progressive visual 
failure.This was done in one eye in the one patient,and in the 
other patient the procedure had to be repeated in the other eye 
within 3 months of the first decompression.In the first patient 
there was no further visual loss in the eye after the 
decompression.The second patient developed bilateral optic 
atrophy despite decompression to both eyes. 
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6. DISCUSSION: 
6.1. Clinical Aspects: 
General: 
The age range and preponderance of female patients in this study 
is similar to that of previous studies.Peak incidence occurs in 
the third decade (1) (24) (25) (26) with the majority of patients 
developing the syndrome between 17 and 44 years of age (1) (26). 
The mean age of onset for Pseudotumor Cerebri was 29 years which 
is similar to the mean age of onset in other studies Ceg. 
yrs in ref. (26);34 yrs in ref. (27);32 yrs in ref. (22) J 
27.8 
It is striking how similar the bar graphs depicting the 
distribution of age of onset are in this study of 30 patients 
compared to that of Johnston's group of 110 patients {20). 
Although sporadic cases below the age of 1 year and after the age 
of 60 years are described,the condition is very uncommon in these 
age groups. 
The figures for patients younger than 12 years in this study are 
representatively,probably lower than those encountered in the 
general population.Children are usually referred to the Red Cross 
Childrens Hospital. 
6.2. Associated Conditions: 
In half the patients in this study,a specific factor in the 
patient's history was thought to be significant.In 4 patients 
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more than one such factor was present.At first glance,the figure 
is somewhat higher than in many studies.The literature lacks 
consensus on what constitutes an associated predisposing factor 
and others which are due to a chance association. 
Johnston's figure of 43.GX for "aetiologic factors" includes 
acute infection,ear infections,head injury and steriods but his 
chart does not mention factors such as menstrual 
disturbances,oral contraceptives and drugs such as Vitamin A and 
tetracyclines (20). 
In the present study as in others,values for incidence of 
menstrual irregularities,pregnancy and oral contraception are not 
adjusted for expected incidence in normal female subjects or 
otherwise normal,obese female subjects.Furthermore some patients 
may have had cerebral sinus thrombosis,a recognised complication 
of oral contraceptives and pregnancy.Some authors have suggested 
that any associated female endocrine abnormalities are simply 
secondary to the increased intracranial pressure.Greer's (28) 
report of 4 patients in whom amenorrhoea preceded the symptoms of 
PTC by 3 to 5 months suggests the contrary. 
Other studies (1) (22) did not mention or include non specific 
flue-like illnesses as a possible associated factor.When factors 
such as menstrual disturbances,acute febrile illnesses,ear 
infections and drugs such as tetracyclines and Vitamin A are 
included as possible associated conditions for the development of 
PTC as they have been in this study,then the figures are similar 
to other studies (19). 
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6.3. Symptoms: 
Headache was by far the most common and persistent complaint 
which caused patients to seek medical attention.It was typically 
generalised,often ill-defined,but not infrequently described as 
throbbing and worse in the morning.The ophthalmologists are more 
likely to see patients with visual symptoms who may not have 
headaches(26).In this study the 2 patients who did not complain 
of headache presented to the eye clinic.In one series of 107 
patients with PTC who were all referred to the neuro- ophthal-
mology clinics at the National Hospital for Nervous Diseases in 
Queens Square,28Y. did not have headaches as a presenting 
complaint (23). 
In the 28 patients who complained of headache in this study,the 
symptom had an intensity or persistence which generally caused 
them to seek medical attention early on.In 2/3 of these patients 
the duration of this symptom prior to diagnosis was less than or 
equal to a month. 
Both vomiting and dizziness were symptoms which some patients 
complained of and again the frequency of these complaints are not 
unlike those of other studies (8) (20). 
It is difficult to know what to make of the complaint of a 
dramatic weight gain just prior to the onset of PTC in one 
patient.Although obesity is often quoted in many studies as a 
common finding in these patients,this is usually a long standing 
problem. 
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6.4. Visual symptoms: 
Diplopia was encountered in 33Y. of patients in this study and 
this frequency is similar to other studies (8) (20).The diplopia 
is usually caused by a VI nerve palsy which generally resolves 
and is ascribed to a non-specific effect of raised intracranial 
pressure. 
Disturbances of visual acuity such as transient visual 
obscurations or fading of vision lasting a few seconds,or visual 
blurring lasting minutes to hours or even persisting was recorded 
in 60Y. of patients.The frequency of subjective visual 
disturbances other than diplopia varies from 30Y. to 72Y. depending 
on the study (1)(19)(20)(22)(26). 
6.5. CLINICAL SIGNS: 
6.5.1. Obesity: 
In virtually all series a high percentage of patients were obese 
ranging from 44Y. (20) to 90Y. (!).Approximately half the patients 
in the present study were thought to be clinically obese.Ahlskog 
(11) has briefly reviewed some of the controversial speculations 
which have arisen suggesting that obese female patients may be 
more prone to PTC because of elevated estrone levels,a hormone 
produced almost exclusively by adipocytes.Increased levels in 
obese females may explain menstrual irregularities not 
infrequently found in these patients. 
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6.5.2. Papilloedema: 
The most prominant physical sign in all series is the presence of 
bilateral papilloedema which was present in all 30 
patients.Unilateral papilloedema was not seen in this group but 
has occasionally been described (29) (30). 
The appearance of the papilloedema cannot reliably differentiate 
between PTC and other causes of increased intracranial 
pressure.While the disc in the peripapillary region may show 
haemorrhage and exudate,haemorrhage at the periphery of the 
retina is very rarely seen (31).If the disc has become 
considerably atrophic,swelling of the disc with recurrent bouts 
of increased intracranial pressure may not occur (31).In patients 
in whom papilloedema subsides,the optic discs may appear 
normal.Some patients have pale "muddied" discs with poorly 
defined margins typical of secondary optic atrophy or 
perivascular gliotic sheathing or both,plus a circumpapillary 
pigment margin.Glistening pseudodrusen,optociliary colateral 
vessels, and atrophic elevation of the disc may also be 
seen(31). 
6.5.3. Sixth nerve palsies: 
30X of patients in this series had VIth nerve palsies and these 
resolved with treatment of the raised intracranial pressure.This 
finding is similar to those described in other studies (1) (20) 
and is thought to be a false localizing sign. 
Two patients had lower motor neurone Facial nerve weakness which 
also disappeared on treatment.This has occasionally been reported 
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in patients with in PTC (7) (32) (33) and is also thought to be a 
false localizing sign. 
7. VISUAL LOSS IN PTC: 
7.1. Mechanism of visual loss in PTC: 
Visual loss in PTC results from the effects of chronic elevation 
of intracranial pressure on optic nerves.A number of factors 
operative at or near the optic disc are considered important.In 
the majority of cases the evidence favours chronic ischaemia of 
the optic disc secondary to optic disc oedema as the major factor 
(23) (34).The normal prelaminar region of the optic nerve head 
lies in a restricted space surrounded by an unyielding Bruch's 
membrane and contains nerve fibre bundles,intervening glial septa 
and fine vessels lying in the septa.Experimental models have been 
developed to investigate the pathogenesis of optic disc oedema in 
raised intracranial pressure. 
Raised intracranial pressure is transmitted by CSF to the sheath 
of the optic nerve.The rise of CSF pressure within the sheath 
produces a rise of tissue pressure in the optic nerve with 
resultant stasis of both rapid and slow components of axoplasmic 
flow in the optic nerve head anterior to the lamina cribrosa 
(35).This accumulation of axoplasm causes swelling of the nerve 
fibres in the optic nerve head perhaps because the lamina 
cribrosa acts as a mechanical barrier to more distal passage of 
neurofilamentous masses (35) (36) (37).The optic disc oedema then 
causes secondary vascular changes in the optic disc and 
peripapillary retinal vessels.The swelling of axons in a 
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restricted prelaminar region compresses the intervening tissue 
and the fine venules and capillaries are likely to be the first 
victims.Venous stasis and slow filling of the prelaminar 
capillaries occurs (34) (35).Compression of the fine vessels on 
the surface of the discs by swollen axons produces 
dilatation,formation of microaneurysms and haemorrhage on the 
disc as well as in the neighbouring retina.Similarly the central 
retinal vein is also compressed producing retinal venous 
engorgement.These vascular changes in the optic disc may produce 
breakdown of the normal optic nerve-blood barrier and lead to an 
accumulation of extracellular fluid which is reported on electron 
microscopy in well-developed optic disc oedema (38). Compression 
of the intervening tissue may be further aggravated by the 
extracellular fluid accumulation.Angiographic studies in such 
eyes have shown circulatory stasis in the perilaminar region of 
the optic nerve (23) (34).0ptic nerves are not compressed in the 
optic canal as the oedema involves only the optic nerve head in 
front of the lamina cribrosa sclera with no oedema of the rest of 
the optic nerve.Compensatory changes such as the formation of 
optocillary shunt vessels and peripapillary subretinal 
neovascularization and decompensatory vascular change may 
contribute to the visual loss.Subretinal neovascularization,with 
subsequent serous detatchment and haemorrhage does not damage 
nerve fibres directly but disturbs pigment epithelium and 
receptors.If haemorrhage involves the fovea,visual acuity is 
usually reduced (23). 
The development of optic atrophy in these patients is also due to 
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ischaemia of the optic disc and fluorescein angiography has 
confirmed reduced vascularity in the atrophic discs (34). 
Sudden visual loss in PTC has been found to be due to ischaemic 
optic neuropathy and subretinal haemorrhage from neovasclar 
membranes (39) (40) (41) (42) (43). 
7.2. Visual deficit and prognosis in present study: 
47X of patients (14/30) in this study had impaired visual acuity 
at time of diagnosis and in approximately half of these the 
impairment was severe (viz: 6/18 or worse). 
40X of patients had impaired visual fields at diagnosis.This 
figure would probably have been higher if all patients had formal 
perimetry (17X of patients did not have their fields formally 
tested).The defects of visual fields in the above patients have 
already been outlined and are similar to those noted in the 
literature.Characteristic field patterns are related to 
involvement of the optic disc.Enlarged blind spots,inferior nasal 
defects,arcuate defects,concentric constrictions and centrocaecal 
and paracentral scotoma may all be seen.The susceptibility of 
these fields in this disorder affecting the optic disc relate to 
regional structural differences yielding certain fibres more 
vulnerable to mechanical and ischaemic damage (26). 
The enlarged blind spot is often found in papilloedema and has in 
the past been attributed to either compression and displacement 
of the retinal peripapillary percipient elements by the swollen 
optic nerve fibres or the Stiles- Crawford effect (the latter 
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phenomenon proposes that wrinkles and folds in the peripapillary 
retina cause light to fall obliquely on photoreceptors,thus 
making the light a less effective stimulus).These long held 
beliefs fail to explain recent observations in which the blind 
spots in patients with papilloedema were reduced to near normal 
size by useing progressively stronger plus lenses.This suggests 
that the enlarged blind spots associated with papilloedema are 
predominantly a refractive scotoma due to local peripapillary 
hyperopia {44).This local hyperopia is induced by elevation of 
retinal percipient elements surrounding the swollen disc. 
In view of these observations that increased blind spot 
represents a refractive error in these patients,the three 
patients noted to have increased blind spots without other field 
defects have been included in the group with normal fields. 
Visual fields,if correctly done,are almost certainly the more 
sensitive means of detecting visual loss in these patients. 
Visual acuity reflects largely macular function.Four patients 
with normal visual acuity had impaired fields when first tested. 
A total of 18 patients {60Y.) had impaired visual function as 
determined by either decreased visual acuity or fields or both at 
the time of diagnosis. 
Visual prognosis: 
As previously indicated,43Y. of patients {13/30 patients) had 
decreased visual function at the time of last assessment.It is 
interesting to note that the majority {12 out of 13 patients) had 
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impaired visual function at time of diagnosis,and only 1 patient 
developed impairment while under observation.More noteworthy,was 
that in 6 of the 12 patients with a residual deficit,visual 
function had deteriorated from the time of first assessment.A 
number of statistical factors must be taken into account when 
considering the figure of 43% as quoted above.This figure does 
not take into account 4 patients who were not followed up and 
another patient who had neither visual acuity or fields tested at 
follow-up visits,so that for these 5 patients no objective 
information is available as to visual function at 
follow-up.Therefore,13 patients out of a total of 25 patients (in 
whom objective measurements of visual function are available) ie. 
52% of patients had a residual visual deficit at last 
assessment.In these 13 patients the mean period of follow-up was 
12 months with a range of 1 week to 3 years (more than 60% of 
these patients were followed-up for 8 months or more). 
Furthermore,this statistic reflecting the number of patients with 
permanent visual deficit due to PTC,is likely to change in the 
future as the period of follow-up continues.Clearly in some of 
these patients the disease was probably still active as at the 
time of last clinical assessment,5 of the 13 patients with a 
residual deficit were still noted to have swollen discs at 
ophthalmology clinic. 
Certain other factors also merit discussion when considering the 
frequency of visual impairment in patients with PTC.The method of 
testing visual function as well as the sensitivety of the test 
will determine the accuracy of the overall assessment of visual 
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function.As previously mentioned not every patient in this study 
had both acuity and fields tested at each visit.Visual field 
testing is time consuming and requires good patient co-operation, 
and a skilled technician to do the test properly.A rushed 
technician in a busy outpatient department who does eg. Friedman 
perimetry without using all the filters or checking each point on 
the screen will produce imperfect field results.Sensitivety of 
field testing is discussed later in the text. 
The extent of visual deficit has been described previously,but I 
have not attempted to determine the resulting disability.The 
disability of visual impairment is largely dependent on the 
visual needs of a particular patient (eg. a pilot who develops a 
slight impairment of acuity eg. 6/9 in one eye or a small scotoma 
is likely to be aware of the defect and seek attention 
early,whereas an elderly retired patient with low visual 
requirement who develops a profound loss of acuity or field may 
often not even be aware of the loss). 
It is clear from the present study that of those patients who 
were followed-up at GSH,52% had a residual impairment of visual 
function after a mean duration of follow-up of 1 year.This figure 
is higher than the frequency of visual loss quoted in a few 
reports in the literature which emphasize the benign nature of 
the syndrome with regard to visual prognosis.The basis for this 
optimism is insecure. 
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7.3. Frequency of visual loss in PTC in other studies: 
Some authors (9) (44) have emphasised the benign nature of the 
syndrome with regard to visual prognosis.This has led some to 
believe that the term "Benign Intracranial Hypertension" refers 
to a benign visual prognosis. 
Rabinowicz et al (45) described 8 patients with chronic 
papilloedema and elevated CSF pressures lasting up to six years 
in whom visual acuity was normal in all (but 2 who developed 
optic disc pallor without apparent functional loss and 3 who had 
persistant nasal defects).As the visual acuity was normal and no 
decompressive procedure was done,the authors stressed the benign 
visual prognosis in this small group of patients.They felt that 
fluctuations known to occur in PTC could explain why in these 
patients the optic nerve withstands pressure so well.They did 
however acknowledge other case reports in the literature of PTC 
in which early development of optic atrophy and ultimate serious 
visual loss is described.They suggested that there may be a 
threshold below which intracranial pressure must fall for 
adequate periods if the optic nerve is to be spared the 
consequences of prolonged pressure.Although the prognosis 
regarding visual deficits is reported to be good in the Lysak 
study (25) ,the selection criteria were arbitrary and CSF 
pressures were not recorded in most of their patients.Guidetti 
(24) also speaks of the "favourable outcome irrespective of 
treatment" in 80 of his patients with PTC whom he was able to 
follow-up for periods ranging from 3 months to ten years.He then 
briefly mentions 12 patients (15i> who had residual visual 
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defects which were either unchanged or worse than when first seen 
and fails to expand on this group.In the Weisberg series (1) only 
3r. of patients had permanent visual sequelae but then field 
examination was not routinely done at follow-up. 
There is ample evidence that visual deficits in PTC are not as 
infrequent as these reports suggest. 
In Dandy's series {46) of 22 cases,11 had evidence of impaired 
visual function at presentation {decreased visual 
acuity,increased blind spot,scotomata or blindness).The majority 
of these patients were treated by subtemporal decompression.Two 
patients were left with permanent visual loss despite the 
decompression.He does acknowledge that his cases may reflect the 
most severe grades as he was aware of other cases who got better 
spontaneously without treatment. 
Foley (7) reported permanent visual impairment in 12 of his 47 
patients C25r.) and this was severe in 3. 
In Baddie's {22) study,patients with PTC were followed up for six 
months to twelve and a half years with a mean follow up duration 
of six years.Twenty three percent (8/34 patients) had visual 
changes resulting from PTC,and in 12r. {4/34 patients) the visual 
deficits were of a marked degree Ceg:secondary optic atrophy and 
progressive field restriction).Subsequently Bulens (47) also 
found that 24r. of his patients (8/33) had visual impairment at 
follow-up and Wall,in his initial retrospective study (48),quotes 
a similar figure of 27r. of patients with PTC (12/45) having 
visual deficits (in 7 of the 12 patients these deficits were 
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permanent and in the remaining 5 the period of follow-up was 
inadequate to determine final outcome).In Sorensen's group of 
patients,25Y. had abnormal fields when first tested (49). 
Orcutt (23) specifically looked at visual function in 107 
patients with PTC,followed for at least 5 years,and found 
detectable visual field or visual acuity loss in 49Y..In addition 
31Y. of the total number of patients continued to deteriorate 
during the period of observation and 6Y. had very severe visual 
loss. 
These figures are similar to those of the present study. 
It is self evident that the incidence of visual loss in many 
series will depend on the method and sensitivety of the test used 
for testing visual function and the frequency which the test is 
done.In many of the retrospective studies,formal visual field 
examination has not been reported in detailed fashion.The visual 
field strategy used is very often not specified in these 
studies. 
Wall (50) subsequently studied 20 consecutive patients with PTC 
with the period of follow-up from the onset of the study ranging 
from 4 months to 2 years.Fourteen of his patients were still in 
the active stages of their disease and the remaining 6 had a 
definate prior diagnosis of PTC but their symptoms and 
papilloedema had resolved.They performed visual field 
examinations serially on these patients using a modified 
Armaly-Drance visual strategy with a Goldman perimiter.This 
technique carefully tests the central 30 degrees and the nasal 
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horizontal meridian.In addition,he also did careful automated 
threshold perimetry (computerized) in the usual fashion with an 
automated perimeter.This was set to carefully test the central 30 
degrees at 6 degree intervals offset 3 degrees from the 
horizontal meridian.He clearly demonstrated that the frequency of 
the visual defect detection was highly dependant on the visual 
field strategy used.He showed that 77.SY. of eyes had visual loss 
detected by automated perimetry and 75Y. of eyes had evidence of 
visual field loss by manual perimetry.These figures were SOY. 
greater than highest rates of detection in prior series.Routine 
screening strategies show visual loss in about 1 in 4 eyes tested 
but with the more sensitive strategies used in this particular 
study 3 in 4 eyes had some visual loss.The morphology and 
frequency of most defects in their patients was similar to those 
in the previous series.Loss on the nasal side of the visual field 
especially the inferonasal loss and constriction of the field 
were the most common defects.They also found a high incidence of 
scotomas of the paracentral,central and cecocentral variety. 
7.4. More sensitive strategies to determine visual loss: 
As therapy for PTC is determined by the degree and progression of 
visual loss these authors (50) recommend that a specific more 
sensitive strategy (such as manual perimetry with the 
Armaly-Drance type algorithm rather than routine screening 
perimetry) should be used for the determination of visual 
loss.These techniques would offer the opportunity for corrective 
therapeutic action in the face of demonstrable deteriorating 
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visual fields long before the patient became aware of already 
extensive visual fall-out. 
Contrast sensitivity testing is a relatively new method of 
evaluating afferent visual function.It can be performed quickly 
and inexpensively using Arden plates by measuring a subjects 
ability to detect differences in shades of grey of a bar grating 
pattern.Loss of contrast sensitivity with preservation of normal 
Snellen acuity has been found in diseases affecting the sensory 
visual system.This test has been shown to be significantly more 
sensitive than Snellen acuity in identifying visual loss in 
patients with PTC.It was also superior in serially following 
patients as there was a significant improvement in contrast 
scores and papilloedema grade but no significant change in 
Snellen acuity when the patients were analysed as a group.The 
advantage of this test is that it can be done quickly at the 
bedside(51). 
7.5. Visual Prognosis in Childhood: 
Contrary to statements in the literature,youth does not seem to 
confirm any protection for visual loss in PTC.Lessell et al (52) 
described 5 children with PTC who suffered permanent visual loss 
of acuity or fields in association with the disorder.All 5 had 
impairment at the time of diagnosis and 2 went on to develop 
further visual failure while under observation.Baker (53) 
reported similar findings in 6 out of 36 children with PTC who 
were left with permanent significant impairment.He noted that 
more patients with dural sinus thrombosis had serious visual loss 
than did those with other associated disease or idiopathic PTC. 
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Children and adolescents should be kept under the same close 
ophthalmic surveillance as has been advocated for adults. 
7.6. Factors predicting visual outcome: 
It is clear that none of the clinical features represented in 
detail in table no.6 on page 26 could be used to predict the 
presence or absence of visual impairment.The presence and 
duration of headache could not be used to determine whether 
patients would have a deficit or not.Of the patients presenting 
with headache there appeared to be a better outcome among those 
with the symptom for more than one month.However the lack of 
objective information of visual function at last assessment in 5 
patients precludes confirmation of this. 
Factors such as age of patient,sex,obesity,precedent febrile 
illness or drug therapy did not predict whether or not patients 
would have visual impairment at diagnosis. 
The severity of the condition as judged by opening lumbar 
puncture did not predict the presence or absence of visual 
impairment at the time of lumbar puncture.Indeed of the 19 
patients with initial pressures greater than 400mm water at least 
6 had normal vision at that time. 
The symptom of transient visual obscurations or blurring of 
vision did not allow prediction of visual loss in this syndrome 
at time of diagnosis,since patients without these symptoms were 
also found to have had visual impairment at time of diagnosis. 
However patients with these symptoms were more likely to have 
visual impairment compared with those without these symptoms. {72r. 
versus 41r. at time of diagnosis). 
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Factors predicting visual loss in other studies: 
Boddie (22) analysed his group of patients to see if there were 
any features of prognostic significance.The age and sex of the 
patients,duration of preceding visual disturbance,headaches,CSF 
pressure,and treatment employed (except for 3 of the 4 patients 
with severe visual loss who had subtemporal decompression 
presumably reflecting the severity of the visual impairment at 
presentation) did not prove to be of prognostic value.One feature 
of note was that 3 of the 4 patients with severe visual loss at 
follow-up had their visual symptoms and signs at the time of 
initial presentation. 
In another study Orcutt also attempted to see whether specific 
ophthalmologic features allow prediction of which eyes may lose 
visual function.Chronicity of papilloedema did not correlate with 
visual loss but those who had atrophic papilloedema had lost 
visual field and continued to do so under observation.Not 
surprisingly,the degree of oedema,which was graded by fundus 
stereophotography,was found to correlate with visual loss (60% of 
the patients with high grade papilloedema developed visual loss 
as compared with lOY. with low grade papilloedema).Furthermore, 
subretinal haemorrhage near the disc was associated with a 
statistically significant increase in visual loss and it was felt 
that this disturbance of vascular supply contributed further to 
the ischaemia of the optic disc (23).Although the symptom of 
transient visual obscurations do not allow prediction of visual 
loss in this syndrome,it is interesting to note that in this 
series the percentage of patients who complained of transient 
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visual obscurations and suffered severe visual loss was 
significantly higher than that of the overall group (89% compared 
to 50%) suggesting that patients who do not · complain of visual 
obscurations are less likely to get severe loss of visual 
function (23). 
7.7. Rate of visual loss in PTC: 
Major reviews describing visual complications of PTC often 
omitted detail on the time course of visual loss (7) (19) (20) (22) 
(24).The pace of visual loss in PTC is often difficult to 
determine since visual fields may dramatically constrict without 
subjective visual disturbance until late.Also the history of 
symptoms is not useful in determining the tempo of visual loss 
C 26 > • 
Visual loss in PTC is usually gradual or stuttering but may be 
insidious and occur any time during the course of the 
disease,even months or years after the diagnosis has been made 
(26) (39) (47). 
Acute visual loss,although not often reported,undoubtedly occurs 
in PTC.The following case report from the present study 
illustrates the precipitous manner in which visual loss may occur 
in a patient with this syndrome.Furthermore,this particular 
patient developed the precipitous visual loss while she was in 
the ward under observation. 
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7.7.1. Case Report: 
A 24 year old female was admitted to Groote Schuur Hospital 
with a complaint of a months' history of increasingly severe 
headache,worse in the morning and accompanied by nausea and 
vomiting.In the week prior to presentation,she had noticed 
transient episodes of blurred vision,occurring intermittently 
throughout the day.She had no history of drug ingestion,recent 
gain in mass or menstrual abnormality and had never received a 
hormonal contraceptive.Examination revealed an obese young 
woman who had bilateral papilloedema.Visual fields and acuity 
were normal on bedside testing as was the remainder of the 
general examination.Radiographs of the skull demonstrated an 
enlarged pituitary fossa and subsequent CT brain scan was 
normal apart from small ventricles and an empty sella.A 
presumptive diagnosis of Pseudotumor Cerebri was confirmed by 
lumbar puncture,the pressure being greater than 500mm water 
and cerebrospinal fluid normal in composition.The patient's 
headache was immediately relieved by the lumbar puncture and 
thereafter treatment with acetazolamide was commensed.The 
following day the headache returned and over the ensuing week 
her visual status deteriorated,despite doses of furosemide and 
dexamethasone,accompanied by repeated tapping of CSF.One week 
after admission her visual acuity had deteriorated to 
detection of hand movements only in the right eye and 6/60 in 
the left eye,with markedly constricted visual fields and 
bilateral 6th nerve palsies.From the third day of 
therapy,headache and symptoms of raised pressure disappeared 
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whereas her visual function progressively worsened.Surgical 
intervention was required and a lumbo-peritoneal shunt was 
inserted.Thereafter the patient's signs improved and 2 weeks 
after surgery,visual acuity was 6/12 in the right eye and 6/18 
in the left eye and the 6th nerve palsies had resolved,but 
residual fields remained severely constricted.One year 
later,her visual acuity was 6/9 and 6/12 but her fields still 
showed constriction with central depression. 
Other isolated reports in the literature have described acute 
visual loss in Pseudotumor Cerebri. 
One patient in the Weisberg series (1) was documented as having 
acute loss of vision occurring over a period of 1 week. 
Acute ischaemic optic neuropathy and subretinal haemorrhage from 
neovascular membranes have caused sudden visual deficits 
(42) (43).Green et al described a patient with PTC who developed 
acute visual loss in one eye and was found to have acute 
infarction of the distal portion of the optic nerve.Troost's 
patient also developed sudden visual loss secondary to retinal 
detatchment caused by haemorrhage from a peripapillary 
neovascular membrane.Subretinal neovascular membranes may be 
stable for weeks to months and then involute or undergo rapid 
enlargement.These lesions must undergo photocoagulation before it 
becomes unsafe to do so (ie. when the lesion spreads beneath the 
capillary free zone) (41). 
In one series,patients had variable rates of vision loss with 
minimal symptoms.The loss was insidious and was not detected 
clinically until it had become profound (26).In this series the 
- 52 -
diagnostic criteria of the syndrome for inclusion of patients 
into the study were carefully met and the 57 patients were 
followed-up for between 5 to 41 years.Of these 57 patients,14 
{25Y.} patients had blinding visual loss or severe visual 
impairment in one or both eyes and in 7 this occurred months to 
years after the initial symptoms. 
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8. DURATION OF ILLNESS AND RECURRENCE: 
A number of factors make it difficult to draw firm conclusions 
about the duration of the syndrome. The onset and end point are 
not easily definable. The duration of symptoms is not a reliable 
indicator of the presence of raised intracranial pressure 
(26).Patients without headache may develop visual deficit without 
being aware of it and symptoms may disappear but the disease can 
still be active.Often patients are discharged before papilloedema 
subsides and even then papilloedema is of limited use in 
determining the duration of PTC (26).The resolution of 
papiloedema may lag behind the resolution of raised pressure and 
the development of optic atrophy may obscure the presence of 
persistently elevated intracranial pressure.Further,when chronic 
gliotic changes develop,it is impossible to use disc protrusion 
to monitor intracranial pressure (49).CSF pressure is the only 
true objective measurement of the persistence of the syndrome.It 
is frequently not done at follow-up especially if the patient is 
asymptomatic and has no visual deficit. 
At ophthalmology clinic where patients were followed-up after 
discharge,attention was directed to detection and prevention of 
visual deficit.Persistent symptoms such as headache were often 
not recorded in the notes.Certainly lumbar puncture was not done 
routinely at last assessment.Also the period of follow-up was too 
short to make meaningful conclusions about the duration of the 
syndrome in some of the patients in this study. 
These reservations must be borne in mind in observing that 10 
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patients had normal discs at last assessment and 14 had 
persistent abnormalities with follow-up periods ranging from 1 
week to 4 years (see detail section 5.7.4. Page 24). 
It is interesting to note that in Sorensen's group of 24 patients 
with PTC who were followed-up prospectively for an average of 4 
years,the optic disc findings at last assessment were similar to 
this study.In 50Y. of his patients papilloedema resolved 
completely and the remaining 50Y. had abnormal discs (gliosis of 
discs,papilloedema,optic atrophy) at last assessment (49). 
No single study has documented the course of this syndrome by 
consistently documenting normal intracranial pressures when all 
symptoms have subsided and clinical signs remained static.Most of 
the clinical studies have been directed to the visual prognosis 
rather than documenting the precise endpoint of the syndrome.All 
these factors previously mentioned are compounded by the fact 
that assessment of the duration of the syndrome should be related 
to the different types of treatment used.This becomes difficult 
as the indications for different therapeutic options varies 
considerably,not only from one series to another,but even from 
patient to patient within any given series.Certain therapeutic 
measures such as lumboperitoneal shunts in severe cases make it 
difficult to judge the natural history of these cases.Despite 
these complex considerations the literature does give guidelines 
and impressions about the course of the disease. 
Foley (7) looked at the onset of first symptoms of raised 
intracranial pressure to the time when papilloedema symptoms 
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vanished.In 33X of his patients (18/55) the symptoms and signs of 
raised pressure lasted less than 3 months,in a further 49% of 
patients (27/55) the symptoms and signs lasted between 3 months 
and 1 year and in the remaining 18X they lasted more than 1 
year. 
Boddie (22) also gives an approximate assessment of duration 
illness in 24 patients in which adequate information about the 
duration of symptoms and signs after diagnosis was available.He 
divided his patients into subgroups depending on treatment 
received.Mean duration of follow-up was 6 years (with a range of 
16 months to 12.5 years).He found that symptoms and signs of 
raised pressure resolved in: 
7 patients (29X) with no treatment -within 1 to 8 months (mean 3 
months) 
7 patients (29%) with treatment with steroids only -within 4 to 
24 months (mean 8.5), 
4 patients (17%) treated with steroids and repeated lumbar 
puncture- within 3 to 14 
months (mean 7.5 months), 
3 patients (13X) with repeated lumbar puncture only -within 2 to 
10 months (mean 6 months), 
3 patients (13%) treated with subtemporal decompression and 
medical treatment -within 2 to 
12 months (mean 5 months). 
Johnston and Paterson's study (20) did not correlate duration of 
disease with treatment.They found that in the majority of 
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patients in their series symptoms did not persist long after 
starting treatment eg in 83 out of 99 patients,who presented with 
headache,the headache disappeared within 3 months of starting 
treatment and in only 9 out of 99 did headache persist for longer 
than a year.However papilloedema persisted for longer (in 44Y. of 
their patients papilloedema resolved within 3 months,in 41% of 
patients papilloedema resolved within 4 months to 1 year and in 
15% of their patients papilloedema lasted longer than a year).In 
a prospective trial,Sorensen et al (49) observed that 70% of 
patients had no symptoms of intracranial hypertension 3 months 
after start of treatment whereas only 20% had normal disc 
appearance. 
In Weisberg's series 27 of the 120 patients had a benign brief 
illness lasting less than 3 months without treatment and with a 
normal CSF pressure on the second lumbar puncture.Noteworthy was 
that in the 120 patients, 50% had been follow-up for at least 2 
to 10 years and none developed a brain tumour (1). 
In another series (47) the duration of papilloedema from 
diagnosis varied between 2 weeks and 2 years.However no lumbar 
puncture was done at last assessment. 
Although PTC is said to be a self limited condition (1) (22) (25) 
(45) there is evidence to suggest that at least in some patients 
it may be a chronic process (26) (49) (54).In the severe cases 
there is no doubt that the disorder may persist for several 
years.Repka et al (55) sucessfully treated 2 patients with 
idiopathic PTC with lumbo-peritoneal shunts.When these shunts 
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were removed electively several years later both patients 
experienced a rapid increase in intracranial pressure and in 1 
this resulted in bilateral visual loss.In another report 6 
patients with PTC (54) had headaches and papilloedema which 
resolved but the serial CSF pressures remained elevated (300 to 
500mm of water) for 3 to 14 years (4 of the 6 had serious visual 
defects which persisted despite resolution of papilloedema and 
headache).The author suggests that these patients may represent a 
subgroup in whom CSF pressures are reset at elevated and constant 
levels reflecting chronic disease.The clinical presentation of 
headache and papilloedema may represent an acute period of 
worsening in what is otherwise a chronic illness (54). 
Recurrence: 
131. of patients in this study (4/30) had relapse of symptoms with 
raised pressure after an initial improvement,occurring within 6 
months of the first episode in these patients. 
In Weisberg's series,12 of the 120 patients had recurrence and 
this occurred within 12 months in each patient. 
In the Johnston series 11 of the 110 patients developed a 
recurrence of the original symptoms and signs after intervals 
ranging from 4 months to 14 years,and 3 of these 11 developed a 
second recurrence giving a total of 14 recurrences.Bulens series 
had a recurrence rate of 61. also occurring from months to years 
after the original episode. 
!!.:...l..:.... Conclusions: 
The above evidence suggests that approximately 30 to 401. of 
patients who present with PTC will have a short limited illness 
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lasting approximately 3 months or less from the time of 
diagnosis.These studies suggest that clinical symptoms and signs 
of raised pressure resolve within 1 year in approximately SOX of 
patients (1} (7} (20} (22} (47}.In the remainder the course is likely 
to be more protracted lasting many months to years after 
diagnosis regardless of treatment.Ten percent recurrence is the 
average recurrence in most series and this may occur even years 
after the first spell (19) (22> (26}.At the time of presentation no 
single factor has been isolated which reliably predicts which 
patients have a short illness and which will have a more 
protracted course.Besides the visual sequelae,patients with the 
syndrome have a good prognosis as long term follow-up has shown 
that they do not develop brain tumour (1) (56}. 
9. INVESTIGATIONS: 
9.1. Lumbar puncture: 
Lumbar puncture should be done on every patient to confirm the 
diagnosis.It should be deferred until CT scan has ruled out the 
presence of an intracranial mass.Rush (19} has previously stated 
that the availability of CT scan has precluded routine lumbar 
puncture in some patients with PTC.Most workers however,would 
take issue with this idea as CT scan will fail to identify 
patients with pleocytosis and may lead to the inclusion of 
patients with inflammatory disease.Causes of disc oedema such as 
sarcoidosis or syphilitic meningitis and meningeal carcinomatosis 
may mimic PTC ( 13} ( 57} ( 58) . 
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~ Radiology: 
9.2.1. Skull Xray: 
Plain films of the skull are usually normal but may show signs of 
prolonged increased intracranial pressure.Symmetrical enlargement 
of the sella is not uncommonly reported. 
9.2.2. CT scan: 
The diagnosis of PTC must be ascertained by the exclusion of 
other causes of papilloedema and increased intracranial pressure 
without localising signs.In the search for such clinically silent 
intracranial lesions such as frontal mass or bilateral subdural 
haematoma the CT scan has almost completely supplanted 
angiography and air encephalography,avoiding the complications 
associated with these invasive procedures (31).The CT scan with 
contrast enhancement shows no abnormality in PTC,with the 
ventricular system either normal or reduced in size. 
In the present study 17Y. of patients (5/30) had small ventricles 
on CT,a figure similar to that in Weisberg's study (59).This 
author observed that the visual impairment in PTC was not related 
to CT abnormalities as visual loss occurred in patients with both 
normal and abnormal CT.Also interesting in the study was the fact 
that all patients with CT evidence of small ventricles had 
symptoms for less than 14 days with CSF pressures of 430mm water 
or more.These pressure values were higher than those with 
patients with normal size ventricles.This pattern of non 
visualization of ventricles and basal cisterns correlated with 
the high CSF pressures (59).In the present study these findings 
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were not corroborated as the presence of small ventricles was not 
found to be associated with statistically significant higher CSF 
pressures compared to those patients with normal ventricular size 
on CT. 
As some patients with non localised increased intracranial 
pressure may have a dural sinus occlusion,it is important to look 
for CT signs of the condition.These include small ventricles and 
a delta sign,which represents a filling defect caused by a clot 
in the saggital sinus. 
9.2.3. The Empty Sella Syndrome: 
Three patients (10%) had an empty sella on CT in this study. 
The empty sella syndrome is sometimes seen and is known to be 
associated with PTC.Chronic elevation of intracranial pressure 
such as occurs in pseudotumor cerebri,if the diaphragma sellae 
were deficient,produces herniation of the subarachnoid cistern 
into the sella turcica,with resultant flattening of the pituitary 
gland and enlargement of the sella (60).The contents of the sella 
have been compressed greatly usually without loss of endocrine 
function function owing to probably a congenital defect in the 
diaphragma sellae.Infrequently,endocrine abnormalities have been 
found in the presence of the empty sella syndrome (61).It has 
been suggested that herniation of the optic nerves and chiasm 
into the empty sella may produce visual loss in these 
patients.However Corbett found that an empty sella conferred no 
statistically significant risk for severe visual loss when 
compared with a normal sella (26).The incidence of empty sella 
syndrome was 24% (14/57 patients) in his series. 
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9.2.4. Angiography: 
The advent of CT scan has largely repaced angiography and air 
encephalography as the investigation of choice to exclude a mass 
in suspected cases of FTC.Since serial angiography is no longer 
routinely done,more dural sinus thromboses occurring in 
association with PTC are probably going undetected.It has been 
shown that patients with underlying dural sinus thrombosis may 
have symptoms,signs and a clinical course which is 
indistinguishable from other causes of PTC (8) (62). 
In the present study,digital subtraction venous angiography was 
only done on 2 patients.On one patient the study was normal and 
on the second patient,a superior sagital sinus thrombosis (with 
no evidence of lateral sinus thrombosis) was demonstrated.Digital 
subtraction venous angiography is an ideal test to exclude dural 
sinus thrombosis.The contrast is administered intravenously and 
it does not carry the same morbidity and risk as arterial 
angiography. 
10. UNDERLYING DISORDERS: 
One patient in this study subsequently developed painful ulcers 
on the lateral border of the tongue and at venipuncture 
sights.Angiography revealed superior sagital sinus thrombosis and 
it was felt she had Behcets disease.CThere are similar isolated 
reports in the literature of Behcet's disease presenting as PTC 
(63)].Another patient developed anterior uveitis one year after 
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the first episode of PTC.Serological screening for collagen 
vascular diseases were all negative and there was no evidence of 
sarcoid or Behcet's disease.This may become manifest in the 
future. 
In the remaining 28 patients,no underlying systemic disease was 
found to be associated with the PTC syndrome. 
In order to place the various approaches to treatment in 
perspective,! have elected to briefly review some of the relevant 
literature concerning the pathogenesis of the syndrome. 
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11. PATHOGENESIS: 
Under normal conditions,intracranial volume includes brain and 
interstitial fluid (about 80r.>,CSF ClOr.) and blood ClOr.>.It is 
recognised that an increase in the volume of one compartment must 
be accompanied by an approximately equal decrease in the volume 
of the other compartments to maintain normal intracranial 
pressureC64). 
Controversy still surrounds the precise pathogenesis of 
the syndrome and presently theories prevail which implicate each 
of the intracranial compartments:Blood, Brain and CSF;and 
postulate that PTC may arise from any one or more of the 
following mechanisms: 
l)An increase in cerebral blood volume. 
2)swelling of the brain itself. 
3)An increase in CSF production or a decrease in CSF 
absorption. 
Each of these mechanisms is discussed in turn,highlighting some 
of the relevant work which has led to these various hypotheses. 
11.1. Cerebral blood volume: 
Cerebral blood volume is affected by homeostatic mechanisms 
controlling cerebral blood flow.These regulatory properties 
enable brain perfusion to remain stable when blood pressure or 
' 
intracranial pressure changes and it is maintained partly through 
myogenic control of arteriolar resistance.Loss of this 
autoregulatory control can potentially result in an increase in 
intracranial pressure(64). 
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There is little evidence to support an increased cerebral blood 
volume being an important mechanism in the pathogenesis of PTC. 
In 1937,Dandy (46) collected 22 patients with PTC in whom a space 
occupying lesions had been excluded.He treated these patients 
with subtemporal decompression to alleviate the symptoms of 
raised intracranial pressure.Thereafter,for several years,he made 
a clinical assessment of the intracranial pressure simply by 
inspecting the site of decompression,noting the degree of 
distension.He made the observation that the decompression was 
almost never consistently at its maximum distension but would be 
intermittently distended with the raised pressure coming and 
going "with surprising rapidity".He surmised that these rapid 
fluctuations observed over the decompression site were due to 
changes in the intracranial vascular bed,which he ascribed to an 
abnormality in vasomotor control. 
Since then,more direct and specific techniques of assessing 
cerebral blood volume and flow have been employed by various 
workers.Nevertheless,the evidence supporting an increased 
cerebral blood volume as a cause of PTC remains inconclusive. 
For example,Raichle and co-workers (65) found a 33% mean increase 
in cerebral blood volume in their 14 PTC patients.However this 
increase was calculated as equal to a 1% increase of intracranial 
contents.They noted that a 5% increase in intracranial contents 
is needed to sustain an elevation in intracranial pressure 
experimentally.Therefore,they concluded that a blood volume 
increase is not a major cause of the syndrome. 
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The limited data to assess blood volume and flow in Pseudotumor 
Cerebri are conflicting but tend to indicate a small increase in 
blood volume and a slight reduction in blood flow (66) (67). 
Part of the problem pertaining to cerebral volume studies relates 
to the fact that any increase in cerebral blood volume in 
patients with PTC may well be a non-specific regulatory response 
to any increase in intracranial pressure (including that eg. 
secondary to the presence of a mass) (31).Not enough is known 
about regulatory changes in cerebral blood flow secondary to 
various stresses.This is compounded by the fact that additional 
factors such as measurement artifact;alteration of blood-brain 
permeability by the use of hyperosmolar contrast media (65);and 
secondary circulatory changes which may accompany anaesthesia of 
trial patients;all serve to hinder the interpretation of the 
results of these studies. 
Added to this are studies which refute the role of cerebral blood 
volme in PTC.Brooks et al (68) measured cerebral blood 
flow,cerebral blood volume and cerebral oxygen utilization with 
the technique of positron emission tomography in 4 patients with 
active Pseudotumor Cerebri and found that these did not 
significantly differ from controls and could find no evidence of 
any deterioration of cerebral oxygen utilization or alteration of 
cerebral haemodynamics. 
11.2. Cerebral oedema: 
The accumulated evidence suggesting that cerebral oedema is an 
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important pathogenic factor in PTC dates back more than fifty 
years and this concept still receives support. 
Early reports (1936) describe the finding of a swollen "wet brain 
with bulging subarachnoid spaces" at surgery (6) and a "bulging 
brain" seen at subtemporal decompression (46).Similar 
descriptions of a "swollen cortex" noted at decompression are 
also to be found in Sahs's series (8). 
In an often quoted study,in 1956,Sahs and Joynt (8) did cortical 
biopsies on ten patients with PTC and concluded that there was 
extracellular and intracellular oedema.They described a "spongy 
appearance of the brain with perivascular spaces swollen with 
intracellular and extracellular oedema scattered throughout the 
entire white matter giving it a cheesy appearance".Furthermore 
one of the patients with cerebral oedema on biopsy was 
subsequently shown to have patent cerebral venous sinuses.In 
another in whom superior sagital sinus thrombosis was proven on 
venography to be the cause of the syndrome,the biopsy revealed 
swelling which resembled that seen in the other cases.The authors 
conceded that biopsy tissue must be accepted with reservation 
because of the small amount of tissue and the inevitable 
distortion that accompanies handling such tissue.However they go 
on to express confidence in the validity of their findings. 
This particular study is important because the findings are 
unlikely to be corroborated by a repeat study as patients with 
PTC generally have a good response to appropriate treatment,and 
the risk of cerebral biopsy in such a group could not be 
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justified for trial purposes. 
The evidence presented for cerebral oedema in PTC in all 
subsequent studies is indirect and cicumstantial. 
In one such study,Raichle (65) pro~ides indirect evidence for the 
presence of cerebral oedema in patients with PTC. 
He showed that the raised intracranial pressure in these patients 
was associated with a significant reduction in cerebral blood 
flow and an increase in cerebral blood volume.He attributed the 
decrease in cerebral flow to tissue swelling as a result of an 
increase in tissue water content.He did this by virtue of the 
fact that his measurements of cerebral blood flow were recorded 
per unit mass of cerebral tissue.Therefore,with this technique 
any increase in tissue volume uncompensated by an increase in 
vascular density would be reflected as a reduction in cerebral 
blood flow through the vascular compartment.However the argument 
that brain swelling accounts for his findings only holds if 
alternate explanations for the reduction in cerebral blood flow 
are ruled out. 
Raichle felt that this reduction in cerebral blood flow was not 
due to impairment of autoregulation,as he demonstrated that 
cerebral perfusion pressure did not approach the lower limit 
required to maintain autoregulation.His findings also did not 
support an increase in cerebral vascular resistance as a possible 
cause for the decreased cerebral blood flow.Lastly,as previously 
mentioned,he calculated that his finding of an increase in 
cerebral blood volume in these patients could not account for the 
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increased intracranial pressure observed in this syndrome.He 
speculated that altered cerebrovascular reactivity at the 
capillary venule level is linked to permeability changes 
resulting in vasogenic oedema. 
The presence of small ventricles,when carefully measured on CT 
scan (69) (70),supports the concept that the elevated intracranial 
pressure results from brain swelling. 
The very nature of this brain swelling merits further comment. 
The primary characterictic of cerebral oedema is an increase in 
the brain water or fluid which leads to the increase in brain 
volume.In those cases of cerebral oedema which are classified as 
"vasogenic" this is the result of alterations in the movements of 
water and solutes across the blood-brain barrier and through the 
extracellular space of the brain. 
It has been suggested,by those who favour the concept that 
cerebral oedema is of prime importance in PTC,that the trigger 
for this oedema is a toxic or an allergic response of the nervous 
system or alternatively a water and electrolyte disturbance 
governed by hormonal factors. 
Some of these interesting endocrine,metabolic and presumed 
allergic or toxic disorders which have occurred in association 
with PTC are briefly described below: 
A number of authors have quoted the association of this 
disorder occurring in patients with Addisons disease.However 
scrutiny of these case reports (14), (15) reveals the 
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development of cerebral oedema with raised intracranial 
pressure in ill patients in Addisonian crisis (some of whom 
died) rather than the characteristic clinical picture 
associated with PTC. 
Although endocrine dysfunction has been suspected in PTC 
because of the association with obesity,abnormalities of the 
female reproductive system,and steroid withdrawal,endocrine 
studies in this syndrome have been unrevealing.Dandy (46) did 
an extensive endocrine work-up in 15 patients with PTC.They 
included diurnal cortisol,ACTH stimulation,urinary ketogenic 
steroids,metyrapone response,cortisol response to insulin 
hypoglycaemia,basal prolactin and levels of FSH and LH as well 
as diurnal temperature regulation and all these studies were 
normal.Likewise Johnson and Paterson (20) found no consistant 
abnormalities in adrenal function.On the other hand,Barber and 
Garvan (71) found normal resting cortisol levels but an 
impaired response to stress (viz:hypoglycaemia).Likewise,Human 
Growth Hormone response to hypoglycaemia and LH response to 
GnRH were also thought to be abnormal in some of their 
patients.These authors concluded that evidence of 
hypothalamic-hypophyseal insufficiency was present in 7 out of 
8 of their patients with PTC.This claim has not been 
substantiated by other authors. 
Dees (72) described the development of this syndrome in three 
children on prolonged steroid therapy for severe asthma.Sugar 
and Grant (16) (17) reviewed the cases of PTC which occurred in 
association with hypoparathyroidism and attributed the cerebral 
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oedema to a nonspecific "electrolyte disturbance" the most 
characteristic being the serum calcium. 
In support of a possible toxic or allergic trigger for the 
cerebral oedema there are numerous reports of the syndrome 
following or occurring simultaneously with a variety of 
infections as previously mentioned. 
If cerebral oedema is an important factor in the pathogenesis of 
PTC then it appears that it may arise from a number of different 
causes.The blood brain barrier is not freely permeable to water 
and certain central neuroendochrine influences (mediated by 
Noradrenalin,CAMP and vasopressin)have been reported to be 
important in the regulation of its permeability (70) (73). 
Cytotoxic oedema is another category of brain swelling that 
occurs but is unlikely to be a factor in PTC.This type of oedema 
occurs as a result of the failure of the cellular sodium pump,as 
in anoxia, and is associated with diffuse brain dysfunction and a 
grossly abnormal EEG. 
An objection which has been raised to attributing the cause of 
increased intracranial pressure,in patients with PTC to oedema or 
brain swelling,is their remarkably well preserved conscious 
state. 
However,the presence of extracellular or "vasogenic" oedema may 
be associated with normal levels of consciousness and a 
relatively normal encephalogram (70) (74) (75).Some workers believe 
that it is only when secondary factors such as tissue tension 
gradients,brain shifts and reduced cerebral blood flow come in to 
- 71 -
operation that neurological function is impaired. 
11.3. Diminished CSF absorbsion: 
The only condition where increased CSF formation has been 
demonstrated in patients is choroid plexus papilloma.This 
potential mechanism for PTC remains unproven. 
Under normal conditions CSF exists in dynamic equilibrium with 
absorption matching production.A condition which results in 
decreased CSF absorption will result in translocation of CSF 
through the foramen Magnum to the distensible spinal subarachnoid 
spaces to compensate for the increased intracranial volume and 
thus prevent a rise in the intracranial pressure.The loss of this 
compensatory mechanism can lead to a marked elevation in 
intracranial pressure. 
The concept of compliance is helpful in the understanding of 
these compensatory mechanisms.Compliance is the ratio of the 
change in volume to the resulting change in pressure (64).At 
normal intracranial volumes the intracranial pressure is low and 
remains so with added increments in volume.Thus compensatory 
mechanisms are adequate,and compliance is high.However as the 
volume increases,compensatory abilities are exceeded and further 
addition of volume is reflected in great increases in pressure 
(64). 
A number of good studies have demonstrated impaired CSF 
absorption with increased resistance to drainage in patients with 
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PTC.In these studies a variety of different techniques were used 
to measure CSF absorption,including plasma uptake of labelled 
albumen (70) (76);isotope cisternography and ventriculography 
(77);constant infusion manometric testing (78) (79) (80) and a 
servocontrolled variable rate infusion technique (81). 
It is argued that the impaired CSF absorption leads to an 
increase in the CSF volume which contributes to the raised 
intracranial pressure. 
At this point it is worth considering the controversy of the 
ventricular system in Pseudotumor Cerebri. 
The Ventricular System in PTC: 
The controversy concerns the argument that if patients with PTC 
have impaired CSF absorption with increased CSF volume resulting 
in raised intracranial pressure,then this would invariably lead 
to dilatation of the ventricular system.Both sides to this 
controversy are briefly discussed. 
Authors whose studies have shown impaired CSF absorption (77) 
in PTC argue that the absence of ventricular dilatation did 
not negate their hypothesis that there is increased CSF volume 
in PTC.Simultaneous lumbar and ventricular pressure readings 
were equal providing evidence of free communication through 
the CSF containing spaces.As the CSF is patently freely 
communicating in these CSF containing spaces,they maintained 
that any increase in fluid volume will be accumulated 
primarily in the capacious and physically most distensable 
part viz. the subarachnoid space.As the entire subarachnoid 
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space is available to accumulate an increased CSF volume,no 
gradients will develop between different parts of the 
system.Therefore they argued that a relative obstruction of 
CSF absorption across the arachnoid villi due to either 
increased resistance in the villi or to a increase in sagittal 
pressure altering the differential which controls CSF 
absorbsion will not result in ventricular dilitation.The 
authors suggest that the production of CSF continues possibly 
at a slightly reduced rate causing increased CSF 
volume.Increase in intracranial pressure helps to restore the 
gradient across the villi to balance the increase sinus 
pressure or resistance within the villi (77).The CSF 
absorbsion control system is therefore reset with an increase 
volume and an increase in intracranial pressure secondary to 
an impaired absorbsion mechanism.They further suggest that 
factors known to be associated with PTC such as venous sinus 
thrombosis reduce absorbsion by increasing the saggital 
pressure and factors such as Vit A,tetracycline and non-
specific infections reduce reabsorbsion by increasing the 
resistance across the arachnoid villi (77). 
The above argument concerning the failure of the ventricles to 
dilate in PTC remains open to criticism as other conditions 
with increased intracranial pressure and increased resistance 
to CSF outflow are characterised by hydrocephalus.Dandy 
observed that the protruding brain seen at the time of the 
decompression operation is scarcely relieved by evacuating the 
fluid from the subarachnoid spaces over the temporal lobe.He 
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reasoned that if the CSF was increased in volume,the 
ventricular space would ultimately participate and therefore 
be enlarged. 
Reid et al (69) showed that measurement of the volumes of the 
lateral and third ventricles by non invasive CAT-based 
techniques in patients with PTC were significantly lower than 
controls matched for age and sex.As the ventricles are in 
direct communication with the subarachnoid space,the existence 
of smaller than normal ventricles argues strongly against the 
primary disorder being an obstruction of CSF absorption at the 
level of the arachnoid villi.In a subsequent paper (70) they 
present some evidence suggesting that resolution of symptoms 
in their group of patients was accompanied by larger final 
ventricular volumes. 
Added to this argument about ventricular size in the "impaired 
CSF absorption" studies are other considerations which should be 
taken into account.In these studies,pressure measurements are 
certainly subject to artifacts and error such as anaesthesia 
induced CSF or venous pressure artifacts,occult leakages, and 
normal fluctuations in pressure gradients between CSF and sinus 
blood.Also,concurrent change in the cerebrovascular compartment 
could introduce measurement artifact suggesting abnormalities in 
the CSF system. 
Accumulated evidence presented thus far,both supports and 
undermines each of the popular contentions that either cerebral 
oedema or impaired CSF absorption is responsible for PTC (82).0ne 
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view is that more than one pathogenic process is operative 
simultaneously and that a disturbance in one cerebral compartment 
will invariably produce a disturbance in another. 
11.4. "Dynamic Interplay" theory: 
More recently,GJerris et al (83) measured intracranial 
pressure,Conductance to CSF outflow (viz:the reciprocal value of 
resistance to CSF outflow) and cerebral blood flow in a series of 
14 patients with FTC.They found a very low CSF conductance to 
outflow and normal cerebral flow in their patients,supporting the 
conclusion that decreased CSF flow is of pathophysiological 
significance in patients with FTC.They propose that patients with 
PTC,regardless of the different possible causes of the 
condition,have a common cerebral defect which causes an increased 
cerebral volume (due to interstitial oedema or alternatively 
increased cerebral blood volume) as well as a defective CSF 
absorption.This combination of defective CSF absortion and a 
"stiff" brain prevents dilatation of the ventricular system.They 
argue that patients with PTC have two fundamental defects - a 
defect in CSF absorption and an increased cerebral volume and 
that this non-compliant combination counteracts dilation of the 
ventricular system. 
Donaldson (84) suggests that FTC is not due to a static increase 
of one component of the craniovertebral box but involves the 
hydrodynamics of CSF flow.Ambient CSF pressure depends on the 
venous pressure in the superior sagittal sinus,the inherent 
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resistance of the arachnoid villi to the egress of CSF,the rate 
of CSF formation and the elastic properties of the brain and 
blood vessels and the capacity of the spinal subarachnoid space 
to expand.It is possible that the dynamic interplay between each 
of these determinants of CSF pressure may be disturbed resulting 
in this syndrome and one or more of these factors may be 
responsible in any one patient.It seems unlikely that a single 
pathophysiologic explanation applies to all patients with this 
syndrome,a conclusion reached by Dandy as far back as 1937. 
There remain more speculations than data available regarding the 
pathophysiologic characteristics of PTC and the limited data 
available do not allow any firm conclusions. 
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12. MANAGEMENT OF PTC: 
When clinical evaluation of a patient with PTC reveals a specific 
causative factor treatment should be directed towards correction 
of that factor.However in many patients no definitive causative 
factor can be detected and many of the known causative factors 
have no specific treatment.No controlled studies have been done 
to show whether weight reduction will result in remission in 
obese patients.Newborg (85) reported remission with weight 
reduction in his group of patients but it is not known how many 
would have remitted spontaneously.Patients in whom PTC develops 
following vitamin A abuse generally have a remission after 
stopping further intake of the vitamin tablets (11). 
A number of factors preclude an assessment of the comparative 
efficacy of the various forms of treatment.The assessment is 
hampered by the limitations of a retrospective analysis in which 
the patient sample is not controlled.Patients were treated in 
different departments within the hospital and clinically assessed 
by different doctors.With regard to the medical therapy there was 
variation in the indications,dosages and duration of the 
treatment.In addition CSF pressures and persistent symptoms such 
as headache were not consistently recorded at follow-up in the 
eye clinic as attention was primarily directed at determining 
visual impairment.Taking this into account as well as other 
factors such as the size of the series,the limited period of 
follow-up and the natural history of the syndrome (with a 
tendency for spontaneous remission to occur) it is clear that in 
the present series meaningful comparisons of the effects of 
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various forms of treatment cannot be made.This in no way implies 
that the various treatment modalities did not influence clinical 
outcome. 
No prospective study comparing the various treatments has been 
done.The fairly high spontaneous remission rate makes evaluation 
of treatment even more difficult.In addition,the clinical 
indications for the various therapeutic options have not been 
clearly defined.Treatment is aimed at relieving symptoms and 
preventing permanent visual deficits.As the syndrome may have a 
varied clinical course and prognosis more than one treatment 
approach may be indicated.The treatment modalities are discussed 
below: 
12.1. Monitoring of visual parameters: 
The need for careful monitoring of peripheral fields cannot be 
overemphasized as loss of vision which may be irreversible is the 
only serious complication of FTC.Visual acuity reflects foveal 
function and does not indicate the state of preservation of 
either the paracentral or peripheral fields.Changes in visual 
fields are the major guides to therapy (31).Visual fields may 
constrict severely before the patient notices any loss of 
vision.Since visual loss may be insidious and often asymptomatic 
for long periods of time visual disaster can only be anticipated 
by monitoring visual fields and acuity.Repeated quantitative 
perimetry is the cornerstone of long term treatment of patients 
with PTC (26) (55).Best corrected visual acuity should be recorded 
carefully at each visit and colour vision should be checked. 
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As PTC may be chronic in some patients it is important to observe 
each patient at frequent intervals for at least one year after 
resolution of headache and yearly thereafter,to monitor for the 
recurrence or for late impairment of vision.Photographs of the 
fundus may helpful! for comparison. 
12.2. Role of visual evoked responses: 
Visual evoked responses (VER> are reported not to be a sensitive 
measure of changes in vision and cannot be used successfully to 
monitor the course of PTC (31).However in a prospective study of 
20 patients with PTC,Krogsaa et al (27) showed a significant 
increase in VER latencies in the single patient who went on to 
develop optic atrophy before any changes in acuity or field 
defects were observed.The VER latencies increased to higher 
pathological values during the development of field defects 
before the optic atrophy became apparent.On this tenuous evidence 
based on their findings in one patient,they suggest that repeated 
examinations of visual evoked potentials in patients with PTC may 
be a sensitive indicator of potential visual failure. 
12.3. Repeated Lumbar Puncture: 
Serial lumbar punctures have a definite role in the treatment of 
PTC.In many cases the disease is self-limited and undergoes 
spontaneous remission. These patients should still be 
followed-up carefully in the future,for visual impairment or the 
rare instance of delayed emergence of a mass (31). 
Half the number of patients (15/30) in this series received 3 or 
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more lumbar punctures. 
Although there is often transient relief of symptoms after lumbar 
puncture it is not clear to what extent this procedure serves the 
therapeutic purpose as usually about 30mls of CSF is drawn off to 
lower the intracranial pressure and this quantity would be 
replenished within about one and a half hours.Surprisingly 
patients often note improved symptoms for some days after a 
single lumbar puncture.There are two possible explanations for 
this.Firstly,a persistent CSF leak may be produced that seals off 
in several days and allows the symptoms to reappear.Secondly, 
transient relief of the elevated pressure may allow some 
compressed intracranial structures to reassume their baseline 
shape.Prolonged or unusually high pressures are needed to produce 
distortion (11). 
At the very least serial lumbar punctures appear to be useful 
early in the treatment.Remissions not infrequently occur soon 
after presentation and lumbar puncture would show 
this.Likewise,as treatment is directed at lowering intracranial 
pressure,this pressure should therefore be measured if treatment 
is shown to be truly effective.Funduscopic pictures are 
unreliable as a means of follow-up as papilloedema resolves 
slowly and one may feel that pressure is dropping as a result of 
treatment when in fact it is being maintained at relatively high 
levels (86).Hoffman argues that no cardiologist would consider 
treatment of systemic arterial hypertension with antihypertensive 
drugs without monitoring the blood pressure,yet some neurologists 
will undertake treatment of intracranial hypertension without any 
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reliable index to gauge treatment effectiveness (86).CSF pressure 
is the only reliable indicator of persistently raised 
intracranial pressure. 
It has been suggested that lumbar puncture should probably be 
repeated at least once before starting any other form of therapy 
except in cases with rapidly failing vision (11). 
12.4. STEROIDS: 
Steroids were used as part of the medical treatment in 
approximately half the patients in this study. 
The literature is inconsistent with regard to the effects of 
steroids on CSF formation.The evidence suggests that steroids do 
not have a significant effect on CSF formation or absorption.The 
therapeutic effects of steroids on raised intracranial pressure 
are considered to be secondary to their anti-oedema effect, 
chiefly via their beneficial effects on endothelial cell 
permeability rather than any direct effect on CSF formation. 
There is no properly controlled study evaluating steroids in this 
condition.However there are numerous reports of the successful 
treatment of PTC with corticosteroids.Paterson (9) reported the 
treatment of six patients with steroids (20 to 40mg of 
prednisone/day) and noted a rapid response in 4,a slow 
improvement in 1 after 6 weeks and no response in 1 patient. 
However this was not controlled,the indications for steroid 
treatment are unclear and the study includes a group who did 
equally well on repeated lumbar punctures.Hooshmand (87) used 
steroids in PTC with good effect but did not describe the 
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indications for its use.Guidetti (24) failed to show a 
significant difference in outcome in 29 patients treated with 
steroids or ACTH compared to treatment with 
diuretics,acetazolamide or glycerol.Once more the study was 
uncontrolled and the indications for the choice of treatmeant are 
not specified.In contrast, Weisberg Cl) felt that his study 
provided good evidence for the effectiveness of steroids in this 
disorder.In 15 patients who did not respond to repeated lumbar 
puncture in the first two weeks and were then treated with 
steroids (20 to 50mg prednisone per day or dexamethazone 6 to 
12mg daily) it was noted that 13 patients responded to the 
treatment and the medication was stopped within two weeks without 
any recurrence.There were also 35 patients who received steroids 
ab initio together with repeated lumbar punctures and had a good 
response within a week.When the steroids were discontinued after 
two weeks the syndrome did not recur.This group includes those 
patients who may have remitted spontaneously or responded to 
repeated lumbar punctures alone.In this study all patients who 
responded to steroids showed an improvement within four days and 
the medication could be stopped within two weeks.No patient in 
this series with PTC who did not show a response to steroids in 
one week subsequently improved on a more prolonged course of 
steroids.Another case report (31) in the literature described a 
good response to steroids,but when reduction of steroid dose was 
attempted after a few months,the syndrome rapidly 
re-emerged.These authors felt that the steroids should be 
discontinued after 2 weeks regardless of the response in order to 
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minimise side effects and prevent possible long term perpetuation 
of the syndrome related to elevated levels of exogenous 
steroids,suppression of endogenous production of steroid and the 
withdrawal of exogenous steroids.Other reports advocating the use 
of a short course of steroids for the condition claim that most 
patients begin to respond within 24 hours (86). 
From these studies it appears that steroids may be beneficial and 
improvement is usually seen within a week.At least in some 
patients tapering the steroids off after two weeks will not 
result in a recurrence (11). 
12.5. DIURETICS: 
12.5.1. Acetazolamide: 
Acetazolamide is a carbonic anhydrase inhibitor that reduces CSF 
production. 27Y. of patients in this study received acetazolamide 
as part of their medical treatment. 
Acetazolamide has been used in a few studies as part of various 
treatment strategies.It was used in 5 patients without success 
in lowering the pressure or relief of symptoms in doses of 0.5 to 
2.0 G daily for two weeks(l).Others have reported unfavourable 
results possibly related to the fact that regular acetazolamide 
has a very short half life (11) (47).Some have found that higher 
doses of between 2 to 4 G daily are required to decrease CSF 
secretion but this dose is often associated with systemic side 
effects including gastrointestinal upset,perioral and digital 
tingling,acid-base imbalance and irritability (48). 
With the exception of choroid plexus papilloma,the rate of CSF 
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formation rarely plays a primary role in the genesis of 
pathological increases in intracranial pressure.For this reason 
Fishman (88) argues that drugs such as acetazolamide and 
furosemide have only a limited place in the treatment of 
conditions such as PTC and brain oedema.Theoretically these drugs 
may be useful in the treatment of raised intracranial pressure 
due to vasogenic oedema because a reduction of CSF formation 
might facillitate the drainage of oedema fluid from the 
oedematous cerebrum to the ventricular system. 
Rubin et al (89) found that under controlled conditions of 
regulated intracranial pressure,acetazolamide administered 
intravenously was found to decrease CSF production in their small 
group of patients.The degree of response varied in individual 
test subjects and the maximum response was always achieved within 
the first 90 minutes and the duration of the response was no 
longer than 30 minutes.However, intravenous acetazolamide may 
cause an acute transient increase in intracranial pressure even 
while inducing a decrease in the rate of CSF formation.This 
pressure change is probably secondary to the effects of carbon 
dioxide accumulation in cerebral tissue,resulting in 
vasodilatation and a secondary rise in intracranial pressure 
(88).Experimentally it is apparent that acetazolamide does not 
significantly inhibit CSF production until over 99Y. of carbonic 
anhydrase activity in the choroid plexus of rabbits has been 
inhibited (90). 
In discussing the use of acetazolamide,Ahlskog (11) stated that 
Lubow and Kuhr had used the long-acting form and claimed good 
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effect and concluded that if acetazolamide is used,it should 
probably be used in the time-release form. 
12.5.2. Furosemide 1 chlorthalidone 1 and the thiazide diuretics: 
Furosemide decreases CSF formation by what appears to be 
interference with chloride transport rather than a direct effect 
on carbonic anhydrase.Experimentally the use of both furosemide 
and acetazolamide together reduce CSF formation by 75Y. in 
rabbits.Although furosemide and some of the thiazide diuretics 
have been used in the treatment of PTC,there is little evidence 
as to their efficacy.In a non randomised prospective 
study,Sorensen suggests that dehydrating therapy with furosemide 
(80mg/day) or Chlorthalidone (100mg/day) in combination with 
acetazolamide (750-1500mg/day) for a period of 6 to 18 months was 
effective in controlling symptoms of raised intracranial pressure 
in the majority of his patients with PTC (49). 
12.5.3. Osmotic Diuretics: 
Reports in the literature have recommended the use of oral 
glycerol as treatment for PTC and other causes of raised 
intracranial pressure (91) (92) (93) (94).Hypertonic intravenous 
solutions have been used in the acute situation to lower 
intracranial pressure in PTC while one waits for neurosurgical 
intervention in the face of rapidly failing vision.Prolonged 
therapy has its limitations because of deleterious side 
effects.The effects of these agents on intracranial pressure, 
causing changes in brain volume,are usually transient because 
complex mechanisms operate to restore cellular volume to normal. 
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The prolonged use of oral glycerol for obese patients has the 
disadvantage of high caloric intake.Nausea and vomiting are often 
induced by its very sweet taste.Glycerol may lead to an increase 
in the plasma triglycerides (95). 
There is poor rationale for the chronic use of hypertonic fluids 
either orally or parenterally because the brain adapts to 
sustained hyperosmolarity of plasma (88). 
12.6. Surgical Procedures: 
Surgery must be considered when medical treatment fails or in the 
case of rapidly failing vision.Procedures such as subtemporal 
decompression and optic nerve decompression have been performed 
but do not address the underlying problem of increased pressure. 
Some clinicians still prefer optic nerve decompression as a more 
direct means to prevent permanent vision loss.Lumbar-peritoneal 
shunting is widely considered to be the surgical treatment of 
choice. 
12.6.1. Subtemporal decompression: 
This procedure is seldom done for PTC in recent years.Earlier 
Greer (96) and Wilson (97) reported their series who underwent 
subtemporal decompression for this syndrome.Indications included 
failure of medical treatment and impaired visual acuity .Despite 
their successes they had a surgical complication rate of 12Y. and 
this included seizures,otorrhoea and brain damage. 
12.6.2. Optic Nerve Decompression: 
Bilateral orbital optic nerve decompression of the perioptic 
meninges has been advocated for relief of papilloedema and 
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threatened visual loss following failed medical therapy (98) (99) 
(100)(101). 
Optic nerve decompression was done one only 2 patients in this 
study.In one patient the procedure was successful (done to one 
eye only) but the other patient developed bilateral optic atrophy 
despite having had a decompression to both eyes.At Groote Schuur 
Hospital,optic nerve decompression is done on one eye at a time 
under general anaesthetic.If both eyes have increasing visual 
loss then the procedure is repeated on the other eye 
approximately one week later requiring a second general 
anaesthetic. 
In a small series of 5 patients,Knight (99) reports that optic 
nerve decompression produced resolution of papilloedema in every 
instance usually over one or two weeks,but that unilateral 
surgery led to resolution of ipsilateral papilloedema alone (ie. 
unilateral surgery produced ipsilateral effects only).CSF 
pressures remained elevated after this procedure in three 
patients and no mention is made of ongoing headaches.In one case 
in which these workers did simultaneous bilateral fenestration 
there was a worrying sudden post-operative visual loss (from R 
6/18 and L 6/12 with constricted fields pre-operatively,to 
counting fingers in each eye post-operatively) but this gradually 
improved over the ensuing months to 6/9 bilaterally.They 
suggested that this alarming complication may be due to a 
disturbance in choroidal circulation either following the sudden 
fall in intracranial pressure or possibly due to excessive CSF 
drainage into the orbits.The mechanism whereby optic nerve 
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decompression reduces papilloedema remains unclarified.The 
surgical defect acts as a CSF shunt but lowers intracranial 
pressure only occasionally and then only temporarily.Prehaps the 
procedure somehow protects the optic nerve from the effects of 
raised pressure.It is unlikely that any incision slit or incision 
window in the optic nerve sheath remains indefinitely patent. 
Perhaps surgery results in adhesions which may protect the nerve 
from the effects of CSF pressure.Optic nerve decompression may 
well result in obliteration of the optic nerve dural window and 
adjacent subarachnoid space by fibroblasts,therebye preventing 
transmission of raised intracranial pressure along the 
subarachnoid space to the optic nerve head and allowing for the 
resolution of papilloedema and field defects (100). 
Small uncontrolled series report good results with this 
technique.Galbraith performed this procedure on a group of 
patients with papilloedema and progressive visual loss,4 of whom 
had PTC (101).He showed resolution of the papilloedema but visual 
deterioration was arrested in only three as one patient had 
progressive atrophy and loss of visual acuity seven months after 
the operation. 
12.6.3. CSF Shunting: 
4 patients received lumbar-peritoneal shunts after failed medical 
therapy.The procedure was successful in 3 as there was no further 
visual deterioration thereafter.In the fourth patient the shunt 
blocked 9 months after insertion and had to be removed and 
ultimate visual status is not known. 
In 1955 Jackson et al (102) reported the value of ventricular or 
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lumbar peritoneal shunting in ten patients with good results.In 
seven of these patients the shunts were still working 
successfully after a year.As the ventricles are normal or small 
in PTC ventricular shunting is particularly hazardous and 
lumbar-peritoneal shunting is the logical 
alternative.Subsequently numerous reports have shown this 
procedure to be an effective treatment when conservative measures 
have failed particularly in the wake of deteriorating vision.A 
lumbar cisternogram is done before shunting to ensure patency of 
the subarachnoid spaces,especially at the foramen magnum.However 
shunting is not without risk and may be complicated by 
malfunction due to blockage of the tube (by eg. omentum or scar 
tissue),displacement of the tube from lumbar canal or peritoneal 
cavity,adhesive arachnoiditis and post operative infection along 
the tubes subcutaneously. 
In 1971 Eisenberg et al (103) described their technique and long 
term results in 34 children who required lumbar-peritoneal 
shunts.Approximately 501. of the patients did not require any 
revision of the shunt.They felt that in those patients who 
required revision of their shunts,they had made small but 
significant improvements in their technique and their subsequent 
results may well reflect this.In Weisberg's series all five 
patients in whom shunts were inserted the result was successful 
with only one recurrence when the shunt blocked (!).Shunting is 
generally effective in preventing further progression of any 
visual loss that has occurred,though visual recovery is less 
certain (104). 
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12.7. Management strategy: 
As PTC has a variable course and prognosis and no controlled 
prospective therapeutic trials have been done to assess different 
treatment strategies,it is likely that more than one treatment 
approach will be effective.However from the extensive data in the 
literature on the subject,certain therapeutic principles can be 
recommended: 
Regular monitoring of the visual parameters as mentioned 
previously is crucial in the management of this syndrome. 
Patients in whom vision is impaired or deteriorating should 
probably be hospitalised for observation. 
If the patient has mild symptoms with no visual impairment,then a 
limited number of serial lumbar punctures should be considered.If 
the disorder persists in spite of repeated lumbar punctures,or 
the patient objects to repeated lumbar punctures or if vision 
becomes impaired then medical therapy should be commenced. 
There is evidence to support a short course of steroids for this 
purpose and a dose of between 40 to 60mg of prednisone daily for 
two weeks,tapering off the dose over a further 2 to 4 weeks has 
been recommended (11).If the symptoms and signs are mild,a course 
of acetazolamide or furosemide or both might be considered in 
place of the steroids. 
Should medical therapy fail with the persistance of severe 
symptoms or if vision should continue to deteriorate,then surgery 
should be urgently considered. 
Lumbar-peritoneal shunting is probably the surgical treatment of 
choice. 
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12.8. Management of PTC in Pregnancy: 
It was not until Foley (7) reported that 16Y. of his patients were 
pregnant at the time of PTC that the association received 
attention.Digre et al (10) studied a group of 21 patients with 
PTC in pregnancy and reviewed the literature on the subject.They 
argued that pregnancy occurs in PTC at about the same rate that 
pregnancy occurs in the general population.The association of 
pregnancy with PTC may only be a measure of the fact that PTC 
affects women of childbearing years.PTC can occur in any 
trimester,although it usually appears in the first half of 
pregnancy in the majority of patients.It has been suggested that 
women with PTC have increased rates of spontaneous abortion (11). 
However the figures for spontaneous abortion in patients with PTC 
have not been shown to be significantly different from those 
expected in the healthy pregnant population (10).Visual outcome 
for pregnant women with PTC is the same as for women with PTC who 
are not pregnant.Procedures currently required to make the 
diagnosis of PTC (eg.Lumbar puncture and CT scan) are not 
contraindicated in pregnancy.These authors strongly feel that the 
development of PTC in pregnancy is not an indication for 
abortion.Almost all the treatment regimens used with non-pregnant 
PTC patients have been used in the pregnant patient.The major 
exception is caloric restriction,which should be avoided because 
of the potential dangers of ketosis on the foetus.There is no 
contraindication to repeated lumbar puncture.Although the use of 
steroids has been associated with birth defects in laboratory 
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animals,this association has not been substantiated in the 
human.Acetazolamide may be used after 20 weeks gestation;earlier 
use has been associated with a single report of sacrococcygeal 
teratoma,but acetazolamide is not a confirmed teratogenic 
agent.The osmotic diuretics probably should not be used in the 
second half of pregnancy because of the potential decrease in 
placental blood flow associated with diminished maternal blood 
volume.The use of chlorthalidone or the thiazide diuretics is 
controversial for the same reason.Foetal growth and maternal 
electrolytes should be followed closely in patients treated with 
these agents.There is no obstetric contraindication to any of the 
possible surgical decompression procedures. 
- 93 -
13. CONCLUSIONS: 
This study has analysed those patients with Pseudotumor Cerebri 
who were seen in a South African teaching hospital over a seven 
year period.Some general conclusions are presented here. 
The first aim of the study was to analyse the spectrum of 
patients with PTC.The preponderance of female patients is 
documented with a male to female ratio of 1:4.The mean age of 
onset was 29 years with 50r. of patients developing symptoms in 
the third and fourth decade.Possible predisposing factors were 
recorded in 50r. of patients.By far the most common predisposing 
factor was the use of one or more drugs known to be associated 
with PTC at the time they developed symptoms. 
The second aim was to document the clinical features of this 
group.Headache (93r.) and visual blurring or obscurations (60r.) 
were the most common presenting symptoms.With regard to clinical 
signs,all patients had bilateral papilloedema,9 patients had VI 
nerve palsies and 2 patients had lower motor neurone VII nerve 
weakness which rapidly resolved with treatment.The latter are 
thought to be false localizing signs. 
The third aim was to determine the visual prognosis of this 
group.52r. of patients (in whom objective measurements of visual 
function at follow-up are available) had a residual visual 
deficit at last assessment with a mean period of follow-up of 1 
year.The majority of these patients (12 out of 13) had impairment 
of visual function at time of diagnosis.In half of these patients 
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visual function actually deteriorated from the time of first 
assessment. 
The fourth aim was to assess the forms of treatment that have 
been used.The need for ongoing careful monitoring of visual 
fields has been emphasized.The various treatment modalities that 
were used on patients in this study have been discussed and 
compared to available data in the literature. 
The fifth aim was to review the literature with regard to: 
comparing the results of other studies to the present one;the 
pathophysiology of the condition;the treatment of the 
syndrome;and the visual prognosis of the syndrome. 
Conclusions regarding these facets have been discussed and the 
similarities between the present study and others have been 
analysed.Loss of vision which may be irreversible is the only 
serious complication of PTC.Visual deficits occurred in a 
significant percentage of patients in this study.The accurate 
determination of visual loss utilizing careful methods and 
sensitive testing of afferent visual function is emphasized. 
Clinical symptoms and signs did not predict which patients were 
more likely to have visual impairment at time of diagnosis. 
However,in this study patients who complained of blurred vision 
or transient obscurations were more likely to have visual 
impairment compared to those without these symptoms. 
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